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Abstract 
 
South Africa is greatly affected by the Human Immunodeficiency Virus (HIV), and the 
prevalence rate was estimated to be 29.5% by testing of pregnant women in December 2005. 
“Roll out”1 of the HIV treatment programme started in 2004. By the end of 2005 there were 
between 980 000 and 985 000 people estimated in need of Antiretroviral Therapy (ART) in South 
Africa, while less than 235 000 people received this treatment.  
 
By conducting observational studies in health care facilities, semi structured interviews with 55 
Health Care Professionals (HCPs), and two group discussions, the present study analysed the 
follow up and care of HIV patients benefiting from the roll out of ART in Grahamstown’s public 
sector. Recruitment of respondents and data collection were carried out between February and 
August 2006. 
 
Since roll out of ART in Grahamstown in May 2004 until September 2006, 687 HIV-positive 
patients have been enrolled on the programme. As the number of patients receiving treatment is 
still very low compared to the need, the programme is growing continually. Observational studies 
showed that though the number of patients receiving ART in local clinics was small, HIV 
patients required special care and attention, and therefore this required more time and focus in the 
clinics. This lead to a great challenge for HCPs who were already coping with stretched limits 
with regard to workload and the opportunity to provide each individual with sufficient health 
care. Results from observational studies and semi structured interviews showed that there were 
few pharmacists and physicians involved in this work, whereas nurses and support staff2 played 
an important role with major responsibilities in the treatment.  
 
HIV patients represented a diverse group with different needs with regard to social and medical 
support. When newly diagnosed, many patients were afraid of stigmatisation from other people, 
and also often believed that ARVs were dangerous. This provided a challenge for HCPs involved 
                                                 
1 “Roll out” is the most common used term in South Africa for the launching of the antiretroviral treatment 
programme. 
2 Support staff includes: Community health workers, community care workers, health educators and clinic assistants. 
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in this work, to ensure that the patients returned for follow up after being diagnosed as HIV-
positive, and that they were well enough educated, especially with regard to adherence, to 
manage the ARV regimen. All interviewees pointed out that work with HIV patients required 
specific training, though sufficient training had not been provided for all HCPs. The majority of 
the interviewees acknowledged the need for prioritising in their work with HIV patients, with 
time constraints being one of the limiting factors. 
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1 Introduction 
1.1 The epidemic in numbers 
Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome (HIV/AIDS) have 
been described as the most devastating epidemic in human history, progressing with a 
catastrophic potential in the near future [1]. The challenges with regard to HIV/AIDS and the 
need for action are elaborated in the 2003 report from the Joint United Nations Programme on 
HIV/AIDS (UNAIDS), where the following statement is made: “HIV infects and kills people, it 
tears apart families, destabilizes communities, slows economies, disrupts social services and 
weakens democracies. Entire societies become vulnerable to implosion” [2]. Its destructive 
effects exacerbate every other challenge to human development [3] and at the same time 
undermine achievements as it leads to countries losing young productive people [4].  
 
According to the UN/WHO, the AIDS epidemic has continued to grow immensely and by the end 
of 2006 an estimated 39.5 million people were living with HIV/AIDS. In sub-Saharan Africa the 
number of people living with HIV/AIDS is 24.7 million. This accounts for two-thirds of the total 
number of people living with HIV/AIDS in an area hosting only 10 % of the world’s population. 
In South Africa there were approximately 5.5 million people living with HIV/AIDS by the end of 
2006 [5]. Since AIDS was first recognised in 1981 it has killed more than 25 million people of all 
ages, from all classes of society all over the world [6]. Total deaths in the world from AIDS in 
2006 were 2.9  million people, and more than five million people will die in the next one to two 
years if they don’t receive ART [7].  
 
According to the UN less than one in five people at risk of becoming infected with HIV have 
access to basic prevention services, and among people living with HIV only one in ten have been 
tested to know their HIV status. There are several factors contributing to reasons why people are 
not aware of their HIV status. One main reason, besides low availability of HIV testing facilities 
in the neighbourhood, is fear of stigma and discrimination as a result of being HIV positive. The 
lack of sufficient treatment for HIV patients in many countries is also seen as a factor. Treatment 
provides a motivation for HIV-positive people to be aware of their status. Without treatment as 
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an option, knowledge that one is HIV-positive can be seen as offering little more than 
stigmatisation [8]. 
 
It is widely agreed upon that simultaneous focus is needed on both prevention of new infections 
and on treatment and care for people already infected in order to address this epidemic [9]. It has 
also been emphasised that access to ART is both a premise for improved health for HIV-positive 
people and promotes prevention by motivating people to undergo HIV testing. “Access to anti-
retroviral therapy is a vital and indispensable complement to both treatment of HIV disease and 
effective HIV prevention. It can restore hope to both health professionals and patients, and can 
assist us in regaining control of this epidemic” [10]. Though access to ART for a large number of 
people is growing steadily, it still remains a challenge in coming as close as possible to the 
United Nation’s (UN’s) goal of universal access to treatment for all who need it by 2010. By June 
2006 there were 6.8 million people in need of ARVs in resource-poor countries, and only 1.65 
million were receiving ART [11]. As a step towards this target, The World Health Organization 
(WHO) and UNAIDS launched the “3 by 5” initiative with the target of providing three million 
people living with HIV/AIDS in low and middle income countries with ART by the end of 2005 
[12]. In sub-Saharan Africa numbers of people receiving treatment increased from 100 000 to 
810 000 between 2003 and 2005, mostly due to increased treatment access in a few countries 
such as Botswana, Kenya, South Africa, Uganda and Zambia [3]. 
 
1.2 About HIV/AIDS 
HIV is a retrovirus which interacts with the immune system and results in a lifelong chronic 
infection. After several years the infection progresses to AIDS and induces dysfunction of nearly 
all elements of the immune system. This is a condition which leaves the patient in a very 
vulnerable situation because of the weak immune system, so the patient has low chances of 
recovery from any kind of infection. Diseases associated with immunodeficiency are called 
Opportunistic Infections (OI) because they take advantage of a weakened immune system. The 
majority of HIV infected people will develop signs of AIDS after eight to ten years if not treated, 
but the rates of the disease progression can be highly variable in infected individuals. Due to long 
incubation period of HIV many people do not become aware of their infection until years after 
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exposure and HIV transmission. This makes it difficult to measure the extent of sexual 
transmission and the relatively higher risk of transmission for females compared to males [13].  
 
Development of HIV antibodies usually takes place six weeks to three months after a person has 
become infected. This is referred to as seroconversion. At this point some people may experience 
a glandular fever-like disease. Any HIV test during this time, based on the presence of HIV 
antibodies, may fail to give correct results due to delay in development of the antibodies. 
 
Though the most widely accepted explanation among scientist is that AIDS is caused by HIV, 
there is a small group of academics who do not believe in an association between HIV and AIDS, 
or who question the validity of evidence of the virus’s existence. The Perth Group (Perth 
Hospital, Australia) is an example of academics of this opinion. They have questioned the 
existence of the virus by claiming that HIV has never been isolated. The issue of ARVs has also 
caused controversy as some academics have stressed the toxicity and denied the value of such 
medication. A professor of pharmacology has stated the following: "I think Zidovudine [AZT] 
was never really evaluated properly and that its efficacy has never been proved, but its toxicity 
certainly is important. And I think it has killed a lot of people. Especially at the high doses. I 
personally think it not worth using alone or in combination at all." [14] 
 
1.3 HIV/AIDS in Africa 
Africa is hard hit by HIV/AIDS and sub-Saharan Africa is the region in the world that has been 
most heavily affected by the HIV/AIDS pandemic. Since the beginning of the epidemic, more 
than 15 million Africans have died from AIDS. The majority of the people living with HIV/AIDS 
in Africa are in their most productive working ages, between the ages of 15 and 49 [15]. To 
reverse the AIDS crisis in Africa there is an urgent need for greater coordination and commitment 
among governments, communities, donors and international organisations to turn principle into 
action on the ground. This was highlighted at the 14th International Conference on AIDS, and 
emphasised by the UNAIDS Executive Director, Dr. Peter Piot, who stated that: “Africa is still 
facing an unprecedented AIDS crisis. The reality is that in sub-Saharan Africa over three million 
people were newly infected with HIV in 2005 – that’s 64% of all new infections globally and 
more than in any previous year of the region. Young people are making up half of these new 
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infections. (…) Increased coordination and scale up of HIV prevention and treatment 
programmes is needed urgently to turn the tide on AIDS in Africa.” [6] 
 
1.4 HIV/AIDS in South Africa 
1.4.1 History of HIV in South Africa 
South Africa has the highest number of people living with HIV/AIDS in the world, and is one of 
the countries with the highest prevalence of HIV infected people [15]. The AIDS epidemic is said 
to be one of the greatest challenges confronting South Africans [10], and HIV/AIDS accounts for 
30% of all deaths in South Africa. This makes it the single largest cause of death in the country 
[16].  
 
According to the available data, based on the results of HIV tests, the prevalence was low during 
the 1980s and increased to a very high level during the 1990s. The first case of HIV diagnosed in 
South Africa was in 1982. During the first few years of the epidemic, the cases were mainly 
among homosexual men. In 1990, the first antenatal surveys to test for HIV were carried out and 
0.8% of women were found to be HIV positive. Since 1990, antenatal testing has been carried out 
annually. In 1991 the number of heterosexually infected people equalled the number of 
homosexually infected. The prevalence at this time was 1.4%. During the years from 1993 to 
1999 the documented prevalence increased from 4.3% to 22.4% [17]. Numbers from 
UNAIDS/WHO AIDS epidemic update December 2006 reports that HIV prevalence among 
pregnant women has reached 30.2%, which is the highest level in South Africa to date [5]. 
Prevalence is highest among women aged 23-34 years. According to this update, the worst 
affected province in the country is KwaZulu-Natal, where the prevalence of HIV-positive 
pregnant women has reached 40%. Due to lack of infrastructure, it is difficult to get a clear 
picture of the HIV/AIDS prevalence. There is also a problem with regard to the validity of the 
common method of measuring HIV prevalence, since this is based on HIV test results from 
pregnant women who attend antenatal clinics. Therefore, prevalence estimates are based on 
results from sexually active women only. Some areas lack the availability of Antenatal Clinics 
(ANC) and not all pregnant women will be required to undergo HIV testing. The extremely rapid 
growth in HIV seroprevalence may result from several conditions that are all determinant for 
exposure to disease. Such influencing factors are social inequalities in income and employment 
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status, mobility such as mass resettlements of populations under apartheid, seasonal labour 
migrations, trade, refugees fleeing; and sexual violence [18]. 
 
1.4.2 South Africa’s response to the HIV epidemic 
The South African Department of Health provides ART free of charge for infected people, but 
the demand is still greater than the serving ability. The latest update for South Africa pointed out 
that the estimated number of people in need of ARVs by the end of 2005 was 983 000 people 
while only about 235 000 received treatment at that point [15]. 
 
The African National Congress has played a major role in the development of South Africa’s 
national HIV/AIDS policies. The National AIDS Coordinating Committee of South Africa 
(NACOSA) was established in 1992 after a conference on AIDS which was brought together by 
the ANC and the apartheid government’s National Department of Health. The progress of the 
NACOSA AIDS plan was assessed in 1997 by the South African National STI and HIV and 
AIDS Review. Built on this review, identifying strengths in the response and highlighting areas 
for further strengthening and improvement, the government launched its five-year Strategic Plan 
for HIV and AIDS in 2000. The four key areas of interventions in the Strategic Plan were: (1) 
prevention; (2) treatment, care, and support; (3) research, monitoring and surveillance; and (4) 
legal and human rights. One of the overall goals in the strategic plan was minimising the impact 
of HIV/AIDS on individuals and families, and improving care and treatment for infected and 
affected people. To achieve their goals the government outlined the following general strategies: 
use appropriate Information, Education and Communication (IEC), increase access to Voluntary 
HIV Counselling and Testing (VCT), improve Sexually Transmitted Infection (STI) 
management, and improve care and treatment for HIV infected and affected people. Capacity 
building through training was one of the key strategies for support of the National HIV/AIDS 
programme [19]. In 2000, the South African National AIDS Council (SANAC) was formed and 
brought together government and civil society. In 2003 the Cabinet instructed the South African 
Department of Health (DoH) to develop a detailed operational plan on an antiretroviral treatment 
programme [20]. 
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HIV/AIDS has been highly politicised in South Africa. Statements and action from political 
leadership concerning the disease and response to it have contributed to controversies between 
the government, national and international scientists, and HIV activists. Controversial statements 
from political leadership ranges from the President publicly questioning the link between HIV 
and AIDS, the minister of health’s declaring AIDS to be a notifiable disease, the announcement 
that neither AZT nor NVP would be provided to pregnant HIV-positive women, and warnings 
about the toxicity of ARVs [21]. The government’s response to HIV/AIDS has been criticised by 
individuals and NGOs, like the Treatment Action Campaign (TAC) for not taking sufficient 
responsibility as shown by the statement: “Absence of strong committed leadership has 
compromised an effective response to the epidemic” [18]. 
 
1.4.3 Health care system in South Africa 
Like most countries in southern Africa, South Africa has built its health care system around 
Primary Health Care (PHC) principles. This means that local clinics offer first-level care and 
refer patients to hospitals when necessary. Since the HIV/AIDS epidemic struck, many clinics 
have been upgraded to provide VCT. In South Africa, clinics have been upgraded as part of the 
prevention programme [22]. 
 
South Africa is one of the most inequitable countries in the world, which reflects the social and 
economic inequities that exist at global level. A large inequity in the distribution of human and 
financial resources exists between the public and the private health sector. There is also an 
inequitable distribution of resources between the rural poor provinces and urbanised provinces. 
The private sector serves those of the population who can afford health insurance, which is less 
than 20% of the population. In spite of the small part of the population who are able to benefit 
from this, the private sector employs more than 70% of the health care specialists and consumes 
more than 60% of the health care budget [23]. For the public sector there is a district-based health 
care system to ensure local level control of health services. Public healthcare is free to pregnant 
women and children under six years; others pay on a means-tested, fee-for-service basis. The 
public health sector includes general hospitals, specialised hospitals, PHC centres and support 
institutions, and serves about 80% of the population [23]. 
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1.5 Antiretroviral therapy 
1.5.1 Combination therapy 
Adequate antiretroviral therapy (ART) for treatment of HIV infected patients consists of a 
combination of at least three different ARVs. ARV medicines are classified as Protease Inhibitors 
(PI), Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTI), Non Nucleoside Reverse 
Transcriptase Inhibitors (NNRTI) or Fusion Inhibitors (FI) based on how they function. 
Zidovudine (AZT/ZDV) was the first ARV to be approved by the Food and Drug Administration 
(FDA) in 1987, and in 1996 the efficacy of combining two or more ARVs became known [24]. 
The need for a combination therapy is due to the high incidence of resistance development of the 
virus if not sufficiently suppressed, and standard treatment guidelines at present advocate the 
combination of at least three ARVs. Antiretroviral therapy for treatment of HIV infection has 
improved steadily and to date there are a total of 21 ARVs approved by FDA for use in the 
United States [25]. Especially in developed countries, new medicines are being approved that 
offer more dosing convenience and improved safety profiles, and some previously frequently 
used medicines are now being used less often as their disadvantages become better defined and 
there are more options [25]. 
 
1.5.2 ARVs available in South Africa’s public health sector 
There are eight ARVs available in the public sector in South Africa, and they make up the 
following two treatment regimens [26]: 
 
Treatment regimen 1:  
Stavudine (D4T) + Lamivudine (3TC) + Efavirenz (EFV) or Nevirapine (NVP) 
 
Treatment regimen 2:  
Zidovudine (AZT, ZDV) + Didanosine (DDI) + Lopinavir, Ritonavir (LPV/r) 
 
Fixed combination therapy is not used in the public sector in South Africa. The limited selection 
of ARVs in the public sector prevents the opportunity for individualised treatment and according 
to the national guidelines all HIV patients will be initiated on treatment regimen 1 when eligible 
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for treatment. The national guidelines also direct that patients who fail on the second line 
treatment continue until there is no further clinical benefit from the treatment [26]. 
 
1.5.3 Costs and availability of antiretrovirals 
The costs of ARVs are of great importance for availability of ART, especially in developing 
countries. In developed countries, pharmaceuticals are often publicly funded through 
reimbursement and insurance schemes, whereas in developing countries, typically 50-95% of 
medicines are paid by the patients themselves. Thus prices of medicines have direct implications 
for access in developing countries. In 1998 the Pharmaceutical Manufacturers Association and 39 
drug manufacturers brought legal action against the South African Medicines and Related 
Substances Control Amendment Act, regarding compulsory licenses and parallel imports, which 
would allow the government to procure essential drugs at cheaper prices [21]. When new 
medicines are protected from low-cost competition for 20 years by patent, resource-limited 
countries are deprived of these medicines for that period. The most important mechanism for 
pushing the prices down is generics competition, price negotiation, differential pricing and pool 
procurement [27]. Within a few years, the prices of ARVs have been reduced to a great extent, 
leading to increased access for ART in low- and middle-income countries. Prices of ARVs are to 
a great extent determined by competition between different manufacturers. In four years the price 
for a triple combination of ARVs has been reduced from $10 000 per year per patient in US to 
$200 per year per patient today [28]. 
 
DOHA agreement 
The World Trade Organisation (WTO) adopted the DOHA agreement in 2001, which asserts that 
the least developed countries have the right to exclude pharmaceutical products from patenting 
until 2016 to address the public health crisis, including HIV/AIDS. Producers of generic drugs 
and major pharmaceutical companies agreed to reduce the prices. [17]. Due to falling ARV 
prices, new sources of international funding and growing political commitment, provision of 
treatment for Africa’s HIV-positive people is an achievable goal [29].  
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1.5.4 Challenges in providing antiretroviral therapy 
Immense challenges are associated with treatment and care for HIV/AIDS patients in resource-
limited settings. HIV patients who present with serious AIDS defining illnesses would in 
developed countries be of specialist’s concern, whereas in most African countries the resources 
available for the care of such patients are limited or frequently nonexistent. It has been claimed 
that money available is often not spent efficiently within expected time frames because of lack of 
visionary leadership, inadequate human resources, poorly developed business plans, or multi-
tiered bureaucracy. Still, based on studies to date, it is suggested that with appropriate training 
and supervision, adherence to ART in resource limited settings will be possible [30]. 
 
Adherence challenges 
In the recent years there has been an intensive discussion about the safety of providing Highly 
Active Antiretroviral Therapy (HAART) in resource-constrained settings and whether or not 
sufficient level of adherence can be achieved. One major risk associated with ART is ARV 
resistance, and the only way to avoid this is to adhere strictly to therapy [31]. Studies have 
identified drug-resistance in up to 21% of persons newly infected with HIV in Europe [32]. It is 
stated in an article on antiretroviral therapy in Africa that adherence to drug treatment is lower in 
Africa than in industrialised nations, and that there is no reason to suppose that resistance 
problems encountered in industrial countries will not occur in developing countries also [31]. 
Due to serious adverse effects, pill burden, lack of knowledge and stigma related to being HIV 
positive, HIV patients face other barriers than non-HIV patients, both regarding acceptance of the 
diagnose and adherence to treatment. The use of traditional medicine in many African countries 
also provides a barrier to both acceptance of, and adherence to, an ART regimen. To minimise 
the chance of negative effects as a result of poor adherence, a strategy involving use of supporters 
has been widely adopted. Use of supporters has been shown to improve adherence among HIV-
positive patients, and is one of the requirements in the National Antiretroviral Treatment 
Guidelines for South Africa [26]. Requirement for a supporter ensures that the patients disclose 
their HIV-positive status to at least one person who can help them adhere to the treatment 
regimen.  
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Another approach to increase adherence is Directly Observed Treatment (DOT) strategy. DOT 
strategy has been studied in Haiti and the outcomes showed that a high degree of adherence was 
obtained [21]. Though this approach was successful in Haiti, other studies have found that DOT 
has been met with varying success in African countries. In Trinidad and Tobago people were not 
willing to let the health care worker come to their home [33]. An operational research study from 
Kenya studied the health care workers’ and the clients’ perceptions of whether a modified 
Directly Administered ART (DAART) approach should be conducted in the clinic or at the 
patient’s home. More than 75% of the clients preferred to have the follow-up and observation at a 
health facility rather than at home due to greater confidentiality and perception of better care 
[34]. A study of the Senegalese government HAART initiative has looked into the feasibility, 
effectiveness, adherence, toxicity and viral resistance, and concludes that results are comparable 
to those in western countries [35]. Another study of HAART among Senegalese adults has shown 
that adherence can be as high in Africa as generally observed in industrialised countries, but the 
type of drug regimen must be taken into account [36].  
 
Lack of health care professionals 
Africa is home to 11% of the world’s population and carries 24% of the global disease burden, 
with only 3% of global health workers. This shortage is one of the most serious problems facing 
antiretroviral treatment programmes [37]. Health professional resources and access to them are 
determinant for the development and maintenance of programmes aimed at treating and caring 
for patients living with HIV. Skilled health care professionals are offered better working 
conditions and better salary abroad, which leads to a drain of human resources from nations with 
declining HCPs. The WHO regional Director General for Africa, Dr Luis Sambo, says that: 
“Africa must reverse today’s dramatic health situation by investing massively in its health 
workers.” It is estimated that rates of health worker migration range from 8% to 60% in African 
countries [38]. 
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1.6 Impact of HIV in South Africa 
1.6.1 Stigma and discrimination 
Social responses of fear, denial, stigma and discrimination have accompanied the epidemic since 
HIV and AIDS was identified. The stigma stems from fear, partly due to lack of knowledge, as 
well as associations of HIV/AIDS with disease and death, and with behaviours that may be 
illegal, forbidden or taboo. This has lead to prejudice against the groups most affected, as well as 
those living with HIV/AIDS. Many individuals affected or believed to be infected have been 
rejected by their family, their loved ones and the community. The association of HIV/AIDS with 
stigmatised behaviours combined with lack of knowledge, can lead to people becoming fearful of 
undergoing an HIV test, and hence contribute to the spread of the epidemic, as many infected 
people are unaware of their status and do not take precautions. When blaming certain groups or 
individuals, the society may fail to take sufficient responsibility for the affected individuals, who 
are often seen as punished with the disease because of their shameful behaviour or 
irresponsibility [38].  
 
A study conducted of concerns about stigma among Eskom workers in South Africa shows that 
workers worry more about stigma from co-workers than discrimination within the workplace. 
Many respondents in the study believe that HIV/AIDS is a punishment for bad behaviour [39]. 
Stigma and discrimination has a great impact on the lives of HIV-positive people and this is 
elucidated by the incident of a South African AIDS activist who was stoned to death in 1998 after 
announcing her HIV-positive status publicly on World AIDS Day [40]. 
 
1.6.2 Impact on households 
Presence of AIDS often leads to households disintegrating, as parents die and children are sent to 
relatives for care. Even though no part of the population is unaffected by HIV, it is often the 
poorest sectors of society that are most vulnerable to the epidemic, and for whom the 
consequences are most severe. Individuals who would have provided the household with income 
are prevented from working either because they get ill themselves, or because they are caring for 
others. Among HIV affected households in Africa, the main coping strategies adopted are 
reported to be: (a) use of savings/take on debt; (b) assistance from other households and (c) 
changes in composition of households [15]. 
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In a study on effects of HIV/AIDS on households in South Africa it is reported that affected 
households suffer from loss of income and lack of food. Approximately 22% of children under 
the age of 15 years have lost a parent and 12% of the households have sent children away to live 
with other caretakers. More than 40% of caregivers took time off from work or school to care for 
the ill person and only 50% of the respondents publicly acknowledged that the sick person they 
were caring for had HIV/AIDS. The researcher concluded that some of the long-term 
consequences of the HIV epidemic are: deepening poverty among the already poor; disruption 
and premature termination of schooling for children, especially girls; increasing childhood 
malnutrition and increasing strain on extended family networks. Few of the families reported that 
they received governmental grants. Among HIV affected households, an average of 34% of 
monthly income was spent on health care, compared to an average of 4% spent on health care in 
non-HIV households [41]. Another study from South Africa shows that households where an 
adult has died from AIDS are four times more likely to disintegrate than those households where 
no deaths have occurred [42]. 
 
1.6.3 Impact on the economy 
HIV/AIDS has played a more significant role in the reversal of human development than any 
other single factor. One such outcome is the negative impact on economies, which also makes it 
more difficult for countries to respond to the crisis. In disadvantaged communities the limited 
access to general treatment and care exacerbates the negative effects of HIV/AIDS. Loss of 
human resources and the negative effect on the economic development affects Africa’s ability to 
cope with the epidemic. Many African countries were already struggling with development 
challenges, debt and declining trade before HIV/AIDS worsened the economic situation. “By 
making labor more expensive and reducing corporate profits, AIDS limits the ability of African 
countries to attract industries that depend on low-cost labor and makes investments in African 
businesses less desirable. It therefore threatens the foundations of economic development in 
Africa” [29]. As labour supply and productivity decreases, the government income declines, but 
at the same time the government is pressurised to increase their spending on health care services 
as a result of rising prevalence of AIDS. In sub-Saharan Africa, the annual medical costs of AIDS 
is estimated to be US$ 30 per capita [4], and cost of ART per patient in poor countries with 
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special agreements is estimated at a minimum of US$148. In comparison, the overall spending on 
public health in most African countries is less than US$ 10 [15].  
 
The HIV/AIDS epidemic has threatened every economic sector in many nations. Loss of skilled 
workers in business and industries leads to lower profits, greater difficulty in delivering products 
and services, and higher costs for production, training and insurance. South African companies 
report that HIV/AIDS is having a significant negative effect on profits [15]. Due to these 
devastating consequences of the epidemic, some companies, like Eskom in South Africa, have 
started to implement HIV/AIDS prevention, care and treatment programmes for their workers 
[39]. It is estimated that without efforts to combat the HIV/AIDS epidemic in South Africa, the 
country will face a complete economic collapse within three generations [21]. 
 
1.6.4 Impact on health sector 
In all affected countries, the HIV/AIDS epidemic brings additional pressure on the health sector. 
The demand for care of patients is growing steadily as HIV infection progresses to AIDS, which 
leads to an increase in hospitalisations. This in turn has a negative impact on the quality of care 
provided in hospitals, with shortage of beds, medication and trained staff. In sub-Saharan Africa 
more than half of all hospital beds are occupied by people with HIV-related diseases [15], and in 
South Africa, HIV/AIDS is a major cause of hospital admissions. Research in South Africa has 
estimated that patients affected by HIV/AIDS on average stay in hospital four times longer than 
other patients [30]. 
 
The epidemic forces governments to increase their spending on health care. However, the public 
health care spending in South Africa has not increased according to growth in Gross Domestic 
Product (GDP), but rather declined as a percentage of GDP. South Africa spends 8.7% of the 
GDP on health, and inequities exist. The private sector share is 5.2% while public sector share, 
which counts for 80% of the population is 3.5% [43]. Large inequalities in per capita expenditure 
on primary health care also exist between provinces. Funding of primary health care (PHC) in 
South Africa for 2003/04 ranges between ZAR753 in Limpopo and ZAR246 in Northern Cape. 
Eastern Cape was second lowest with regard to funding of PHC, spending ZAR106 per capita.  
                                                 
3 ZAR100 = US$15.5 (Cited 20.11.2006. Available from: www.dnbnor.no/person/kalkulatorer_og_verktoy/) 
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In Eastern Cape the total spending on ARVs for 2005 was about ZAR19 million. This places 
ARVs on top of the ABC analysis4 in the province [44].  
 
1.7 International mobilisation to fight HIV/AIDS 
1.7.1 International initiatives for improvement of health 
The inequality in health was addressed in 1978 on the International Conference on Primary 
Health Care, Alma-Ata, with an aim for health for all by year 2000 [1]. In the Alma-Ata 
declaration it was stated that: “All governments should formulate national policies, strategies and 
plans to launch and sustain primary health care as part of a comprehensive national health system 
in coordination with other sectors. To this end, it will be necessary to exercise political will, to 
mobilise the country’s resources and to use available external resources rationally.” [45] An 
analysis of the complex interrelation between poverty and AIDS states that though the target of 
health for all was not reached, the resources to win this war are not lacking. It further states that 
the concept of PHC has not failed. What has failed is rather the political will of ensuring that 
PHC goals were achieved through a more equitable redistribution and use of the world resources 
[1]. 
 
A declaration of commitment on HIV/AIDS was adopted at the UN General Assembly Special 
Session in 2001. Leaders from 189 member states committed themselves to comprehensive, time-
bound targets for the delivery of effective HIV prevention, treatment, care and support needed in 
order to reverse the global epidemic by 2015. The failure of delivering ART to people is a global 
health emergency which has been addressed by WHO’s “3 by 5” initiative. 21 countries have 
reached the target of providing treatment for at least 50% of those who need it by 2005. But 
according to the report there are still significant weaknesses in the response to HIV, especially 
with regard to prevention programmes that are failing to reach those at greatest risk, and failing to 
meet the aim for educating the majority of young people about HIV. Half of the countries 
submitting reports to UNAIDS acknowledged the existence of policies that interfere with the 
accessibility and effectiveness of HIV-related measures for prevention and care, such as laws 
                                                 
4 ABC Analysis assembles data from recent or projected procurements to determine where money is actually being 
spent, allowing managers to focus first on high-cost items when considering ways to reduce procurement costs. 
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criminalising consensual sex between males, prohibiting condom and needle access for prisoners, 
and using residency status to restrict access to prevention and treatment services [3]. 
 
In March 2006, with participants from 52 African countries, the Brazzaville commitment was 
adopted with the purpose of scaling up a comprehensive HIV response in Africa. The meeting 
was organised by the African Union (AU), with support from UNAIDS, Economic Commission 
for Africa (ECA), WHO and the Department for International Development of the UK 
Government. The commitment sets a concrete agenda for action to scale up comprehensive HIV 
responses in Africa. The agenda includes developing national account systems to monitor 
expenditure and resource allocation to accelerate the achievement of the target, facilitate reliable 
supply of ARVs, and to strengthen relevant policies [46]. 
 
1.7.2 ARV design in resource constrained settings 
Optimal equitable allocation strategy 
Operations Research5 (OR) techniques have been used to determine the optimal strategy for 
allocating ARVs among health care facilities (HCFs) in KwaZulu-Natal (KZN) in order to satisfy 
the equitable criterion that each individual infected with HIV in resource-constrained regions has 
an equal chance of receiving ARVs. They conclude that in order to achieve the greatest degree of 
equity for individuals with HIV in KZN, the HCFs should serve a region of 40 to 60km, and they 
suggest the use of mobile clinics. An increased number of HCPs is recommended, and all 
available health care facilities should be used. The Optimal Equitable Allocation Strategy 
(OEAS) was compared with two other ARV allocation strategies:  
 
a) Allocating ARVs only in the urban areas and  
b) Allocating ARVs equally to all HCFs. 
 
The results showed that the OEAS improved equity in treatment accessibility compared to the 
two other ARV allocation strategies [47]. 
                                                 
5 OR, also called “delivery system research”, refers to subjects and disciplines supporting the design and 
improvement of the systems that allow effective prevention, treatment and care reach those who need it. World 
Health Organization, The World Health Report 2004 – Changing History, chapter 5. Available from: 
http://www.who.int/whr/2004/chapter5/en/index4.html (Cited: 05.09.2006) 
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Equity challenges 
When designing ART programmes where resources are scarce there are challenges concerning 
equity. These challenges stem from an inequitable distribution of human and financial resources 
and are reinforced by political inconsistency. When working towards universal access to ART in 
poor settings, different aspects need to be addressed. These aspects are: criteria for selection of 
those eligible for treatment; adherence to ARVs; monitoring ART for safety, effectiveness and 
acceptability; sustainable financing of ARVs and requirement for governments to commit for a 
long time; risks needed to be prepared for. The discussion is now shifting from ethical and 
philosophical concerns to practical and concrete steps to be taken and critical issues to be 
considered [48]. The WHO and UNAIDS have identified three core principles that should 
underlie every effort to fairly distribute ARVs: Urgency, equity and sustainability [12]. 
 
When only a small portion of patients eligible for treatment can access it, due to limited resources 
and health care in short supply, different rationing strategies are applied to decide how scarce 
resources can be most equitably distributed, e.g. targeting specific populations (HIV-positive 
mothers or new infants, health care workers, teachers, poor people), restrictions by geographical 
area, co-payments and “first come first serve”. Different ways of rationing ART will have 
different social and economic consequences for African populations. Understanding these 
outcomes is important for making decisions that will help combat HIV/AIDS and to sustain 
economic development [49]. Some prioritise the sickest to receive ARVs first. Others argue that 
it’s better to prioritise those who will respond better to treatment, which are generally not the 
sickest patients [50].  
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1.7.3 The World Bank’s Global HIV/AIDS programme: Elements of effective 
programmes 
A survey of experience in provision of ART in developing countries has shown that successful 
programs rely on [51]: 
1. Simplified, standard regimens of fixed dose therapies 
2. Simplified clinical monitoring 
3. Provision of consumer-friendly adherence support 
4. Maximum use of human resources (including non-professionals, families, and community 
members) 
5. Active community involvement 
6. Integration and phased scale-up 
 
1.7.4 Need for health research 
Health research is necessary to give evidence based recommendations on how to combat poor 
health and disease, and operational research (Appendix 1) carried out in the initial stages of the 
ART programme is crucial for the scale up of the universal access to ART and development of 
new treatment sites. As the scale up for universal access to ART expands, new treatment sites for 
ART will develop. It is important to document the work carried out to determine future 
requirements in effectively implementing the ART programme in resource-constrained settings.  
 
1.7.5 Antiretroviral therapy programme in Grahamstown, South Africa 
The Antiretroviral treatment programme was initiated in Makana Local Services Area (MLSA), 
Eastern Cape in 2004. After initiation of this programme, operational research has not been 
conducted to identify and document how different HCPs work together and provide treatment and 
follow-up for the HIV patients enrolled on this programme.  
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2 Purpose 
 
2.1 Objectives of the study 
 
The objectives of this study were to conduct operational research to: 
a) Analyse the role of the different HCPs in antiretroviral treatment and follow-up of HIV 
patients at Makana Local Services Area (MLSA) 
b) Based on the above findings, identify facilitating and constraining factors of the present 
system operating in MLSA 
 
The aim is also to provide the different units of the health care system with information about the 
current work carried out in Grahamstown’s public sector based on the findings of the study. 
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3 Material and method 
 
3.1 Setting 
This study was conducted in Grahamstown, which is part of Makana Local Services Area sub-
district in Cacadu district, the Eastern Cape Province of South Africa. Figure 1 shows a map of 
the nine provinces of South Africa. 
 
 
Figure 1: Map of South Africa 
 
3.1.1 Health care services provided in Makana Local Services Area 
The MLSA public health system consists of three hospitals and 33 clinics (including mobile 
clinics). Patients who are diagnosed with a chronic disease are ideally referred from the local 
clinic where they present with their problem, to the PHC centre or the local hospital for therapy 
and monitoring. When stabilised on treatment the patients are referred to the clinic closest to their 
home for continued treatment and follow-up monthly. This system is referred to as a referral 
system, which is also the structure that has been adopted for the ART programme. The health 
care facilities providing ART in Grahamstown’s public sector are shown in table 1. 
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Table 1: Health care facilities providing ART for HIV-positive patients in Grahamstown  
Hospital: Settlers Hospital (down-referring site) 
Primary Health Care Centre: Settlers Day Hospital 
Primary Health Care Clinics Ragland Road Clinic 
Anglo African Clinic 
Joza Clinic 
V. Shumane (Tantyi Clinic) 
Middle Terrace Clinic 
N. G. Dlukulu (Extension 7) 
 
3.1.2 Distribution of Health Care Professionals in public sector in Grahamstown 
The operating referral system is organised in such a way that the majority of human resources 
with higher education (specifically physicians and pharmacists) are located in the hospital and the 
PHC centre, whereas down-referral clinics are operated by a team of registered nurses and 
support staff6. A doctor is available in the clinics on specific dates, and in case of complications 
there is an opportunity to either refer patients to hospital, or request patients to come back on the 
specific date when the doctor is available. 
 
3.2 Material 
3.2.1 Observations 
One hospital and two down-referral clinics were the basis for the observational studies, as shown 
in table 2. 
 
Table 2: Observational studies carried out in Grahamstown’s public health sector 
 Name of health care facility 
Referring treatment facility: Settlers Hospital 
Down-referral clinics: 
 
Settlers Day Hospital 
Raglan Road Clinic 
 
3.2.2 Pilot study 
Eleven informants were included in a pilot study of the questionnaire. To include the variety of 
health care professionals involved with HIV-positive patients in Grahamstown, the following 
professions were included in the pilot study: pharmacists, nurses, community health workers and 
a dietician. 
                                                 
6 Including the categories: community health worker, community care worker, clinic assistant, health educator 
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3.2.3 Semi structured interviews 
The informants for the questionnaire consisted of 6 males and 49 females, all South African. Of 
these, 78.2% had been working with HIV-related work for more than one year. The working 
experience in the area of HIV/AIDS ranged from two months to 20 years.  
 
The sampling frame for the structured interviews, as shown in table 3, consists of all categories of 
HCPs involved with HIV patients in governmental treatment facilities in Grahamstown. Fifty five 
HCPs from two hospitals and six primary health care clinics were identified as potential 
respondents. All the selected respondents agreed to participate in a one-on-one interview, giving 
a response rate of 100%. 
 
Table 3: Participants for structured interviews (n=55) 
Profession Number 
Professional nurses 23 
Community health workers 15 
Pharmacists 4 
Health educators 3 
Community care workers 3 
Clinic assistants 2 
Doctors 2 
Social worker 1 
Dietician 1 
Nursing assistant 1 
 
3.2.4 Group discussions 
Group discussions were conducted with key stakeholders at the District Health Office, including: 
district pharmacist; clinical sister and MLSA clinic supervisor; and at Settlers Hospital, 
including: hospital pharmacist, programme coordinator, three doctors and a nurse. The 
participants in these discussion groups had been involved in the work since the preparing of the 
programme, or since an early stage in the roll out of the ART programme.  
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3.3 Method 
Three methods were used in the study: observations, semi-structured interviews and group 
discussions. 
 
3.3.1 Observations 
Observational studies were carried out between February and March 2006 in order to document 
the treatment structure and to gather background information for the preparation of a structured 
questionnaire. Table 4 shows what the observations included at the different health facilities. 
 
Table 4: Observational studies conducted 
Name of health care facility Observations  
1. Settlers Hospital:  
 
Dispensing of ARVs 
Patient/doctor interaction 
Patient/pharmacist; ARV counselling 
Patient/support staff; patient education 
Review meeting/ HCP cooperation 
2. Settlers Day Hospital: Patient/pharmacist; ARV collection 
3. Raglan Road Clinic: 
 
Patient/support staff; VCT (counselling) 
Patient/nurse; VCT (testing), screening new 
patients, ARV collection 
 
3.3.2 Pilot study 
A pilot study was conducted in May 2006 and only a few improvements were made to the 
questionnaire.  
 
3.3.3 Semi structured interviews 
Prior to the preparation of the questionnaire the researcher was introduced to management at all 
clinics by the district pharmacist, to inform them about the planned work. All informants for the 
structured interviews were contacted by the researcher at the clinic/hospital prior to the interview 
to inform them about the purpose of the study and to ask for their participation. Interviews were 
scheduled when the consent was obtained verbally, and written informed consent (Appendix 2) 
was obtained from each respondent on the day of the interview. Prior to the intended interview 
either a phone call or a personal visit to the health care facility was made to confirm the 
interview. The interviews were carried out between June and August 2006. Each interview took 
approximately 35-45 minutes to complete and was conducted by the researcher with a tested 
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structured questionnaire (Appendix 3). Interpreters were not essential because all respondents 
could speak English. 
 
3.3.4 Permission for research 
Permission to conduct the survey was obtained from Eastern Cape Department of Health 
(Appendix 4), Rhodes University Ethical Committee (Appendix 5), Makana Municipality 
Department of Health (Appendix 6) and management at the different clinics and hospitals. 
Access to clinics for observational studies and for interviews was allowed by the local authorities. 
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4 Results 
4.1  HIV treatment structure in Grahamstown 
4.1.1 Description of the treatment structure in Grahamstown 
The following section documents the treatment structure of the ART programme in 
Grahamstown’s public sector.  This Information was gathered from observational studies 
conducted from February to March 2006. Observations were done at both referring and down 
referral health care facilities in the ART programme in Grahamstown, and details on what the 
observations included is specified in the section for methods, table 4.  
 
HIV patients living in Grahamstown who use the public health care facilities are seen either at 
Settlers Hospital or at one of the clinics that Settlers Hospital down refers patients to, depending 
on which stage of the treatment programme they are in. The HIV patients seen at Settlers 
Hospital are the patients who are newly on treatment and those who come for check-ups with the 
doctor in case of complications. Figure 2 shows the public health care facilities providing ART in 
Grahamstown, and the treatment sites where observations were carried out are shown in yellow.  
 
Settlers 
Hospital
Settlers
Day
Hospital
Raglan
Road
Joza
N. G. Dlukulu
(Extension 7)
Middel
Terrace
V.Shumane
(Tantyi)
Anglo African
(Town Clinic)
Figure 2: Public health care facilities providing antiretroviral therapy in Grahamstown 
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4.1.2 Health care professionals involved at different stages in the antiretroviral treatment 
programme 
Ten categories of HCPs, as listed in table 3, are involved in the work with HIV patients in the 
public treatment facilities. They contribute to the patients’ health care at different stages and have 
different responsibilities in this work. Figure 3 shows the process from the patients’ point of entry 
to the HIV treatment programme, and at which stages the different HCPs are involved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Structure of antiretroviral therapy programme in Grahamstown’s public sector 
 
Step 1 
The patients come to their local clinic for Voluntary Counselling and Testing (VCT). Normally 
VCT is done on specific dates, and will be carried out the same day as the patients request it. First 
a pre-test counselling is done by a CHW to ensure that the patients know the consequences of the 
test results. The CHW discusses with the patients whether they are ready to undergo HIV testing. 
The tests are done by a registered nurse, and with the tests7 currently being used, results are 
available after 5-10 minutes. After HIV testing, a routine post-test counselling is done by a CHW 
                                                 
7 Pareekshak® HIV-1/2 Triline Card Test, FIRST RESPONSE HIV CARD TEST 1-2.0 
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who discloses the test results to the patients. During this first visit to the clinic, the patients are 
seen by a registered nurse and a CHW.  
 
Step 2 
The patients come back to the clinic for follow up if testing is HIV-positive. Blood sample for 
CD4 counts are taken every six months during the time between a positive HIV test and initiation 
of antiretroviral therapy. Blood samples are sent to Settlers Hospital and results are disclosed to 
the patients during their next visit. When the patients are in the WHO stage two (Appendix 7), 
they are started on antibiotic prophylaxis and trained in adherence. This is part of a patient 
readiness programme, which implies that the patient is not initiated on ART without being 
prepared for taking medication regularly. 
 
Step 3 
Before patients are started on ART, either a social worker or a CHW who has gone through 
specific training visits the patients at home. This is to gather information about the patients’ 
family and economic situations, and to identify factors influencing the patients’ ability to cope 
with the treatment and the disease. A standardised scheme is used to gather this information. 
 
Step 4 
When the home-visits are completed and patients are trained sufficiently in adherence, one of the 
nurses from the clinic presents the patients’ cases at the weekly review meeting at Settlers 
Hospital. During the review meeting, doctors, nurses, the social worker and the pharmacist are 
present to discuss whether the patients can be initiated on ART. If a patients is ready to start 
treatment, the nurse is given a date for the patient to be seen by the doctor at Settlers Hospital. 
 
Step 5 
When patients have been referred to Settlers Hospital for initiation of ARV treatment, they are 
first seen by the doctor. While seen by the doctor they receive counselling on the disease and 
information about the medication and possible adverse effects. Then the medication is dispensed 
and the patients are provided counselling on adherence and how to use the medication, either by a 
pharmacist or a nurse on the same day. This counselling lasts for approximately 30-45 minutes. 
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The patients are given 28 tablets to last for four weeks, and are instructed to bring back any 
tablets left so that the pharmacist or the nurse can do a pill-count to indicate level of adherence 
during the patients’ next visit. 
 
Step 6 
After the patients are started on ARV treatment in the hospital they are stabilised there for three 
to six months, based on their condition. During this time the patients return for review after two 
weeks, and then for check up and collection of medication monthly thereafter.  
 
Step 7 
After the stabilising period of three to six months, the patients are referred back to the local clinic 
for follow up and ARV collection, a procedure which is called “down-referring”. There are seven 
down-referral clinics, which all receive ARVs pre-packed from Settlers Hospital for each patient. 
The district pharmacist collects the medication from the dispensary at Settlers Hospital and brings 
it to the different down referral clinics once a month. At the local clinic, the patients meet 
monthly with a registered nurses and support staff. In one of the clinics, the monthly ARV 
collection also includes meeting with a pharmacist. Every six months blood samples are taken to 
check among other among others, the patients’ viral load, CD4 count, full blood count and 
Haemoglobin. 
 
Step 8 
Patients who receive medication at the clinic monthly are referred back to Settlers Hospital if the 
health worker at the clinic sees the need for an appointment with a doctor. The patients are 
referred to the doctor if they complain about their health and either adverse effects or poor 
response to medication are suspected, or if their weight drops by more than two kilograms in one 
month. The patients can also be referred for counselling with a dietician or a social worker if 
necessary. 
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4.2 Follow up of HIV patients in public sector 
Information in chapter 4.2 through 4.4 shows the results from the semi structured interviews with 
HCPs at public health care facilities providing the ART programme in Grahamstown. 
 
4.2.1 HCP characteristics  
All the respondents of the questionnaire were South African. The majority of the respondents 
shared the same first language as the patients, either: Xhosa, Afrikaans or English. The 
distribution of the HCPs’ first language among these three is shown in table 5. Of all respondents, 
90.9% reported that they had not used a translator during the previous seven days. All 
respondents except three reported that they could communicate in Xhosa, and all of the 
respondents with English as their first language could speak either Afrikaans or Xhosa in 
addition. 
 
Table 5: First languages of health care professionals interviewed (n=55) 
First language Percentage of the respondents 
Xhosa 76.4% 
Afrikaans 12.7% 
English 10.9% 
 
Table 3 shows the sampling frame for the study, and except for two groups this graph also 
represents the whole picture of HCPs involved8 in work with HIV-positive patients in 
Grahamstown’s public sector at the time when data was gathered. There are only two pharmacists 
involved in the work with HIV patients on regular basis, while four pharmacists were 
interviewed. Two of the pharmacists who were interviewed were involved in this work with HIV 
earlier, or they contributed to the work only when it was needed. Two support staff were 
identified after data collection, and they were not asked to participate in the study. 
 
                                                 
8 Based on information from management at each health care facility and district office department of health 
regarding which of the HCPs are involved in the work with HIV-positive patients 
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4.2.2 Patient and Health Care Professional interaction 
4.2.2.1 HCP involvement 
Figure 4 shows how many of nurses and support staff that were involved in the different work 
tasks and table 6 shows the share of nurses and support staff who reported doing these different 
work tasks. 
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Figure 4: Nurses and support staff’s different work tasks : a) Counselling in VCT, b) Testing in 
VCT, c) ARV collection, d) Counselling of patients starting on ARVs, e) follow-up between testing 
positive and initiation of treatment, f) Home visits 
 
 
Table 6: Number of health care professionals involved in different work tasks (n=55) 
Work task All respondents Nurses Support staff 
Counselling in VCT 40 19 20 
Testing in VCT 22 21 0 
ARV collection 36 20 11 
ARV counselling 38 17 16 
Follow up prior to ART initiation 43 23 16 
Home visits 24 2 18 
 
The time that HCPs spent with patients differed for first-time and follow-up visits. As shown in 
figure 5, more time was generally spent with the patients during their first visit than during follow 
up. For first time visits, time spent varied between less than ten minutes and over an hour. Within 
this time range, 25-40 minutes was the most frequently reported time spent for first-time visitors. 
Time spent for follow up visits ranged from less than ten minutes to 45-60 minutes. The most 
frequently reported time spent for follow up visits was 10-20 minutes. 
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Figure 5: How much time health care professionals spent with patients during first-time 
and follow-up visits 
 
The respondents reported that patients generally came to the health care facility without 
appointments, and only for ARV collection were patients supposed to come on specific “to come 
again dates”. Some of the HCPs emphasised that they encouraged patients to come back to the 
clinic before the scheduled date if they experienced any problems, and 96.4% of the respondents 
reported that the patients could meet them without an appointment. One nurse reported that she 
thought one of the most important issues to talk about with the patients was for them to come 
back if they experience problems. Many of the respondents reported familiarity with the patients 
on the programme, which enabled them to recognise the patients. Of all the respondents, 76.4% 
said that they could recognise all or most of the patients from their previous meeting. 
 
4.2.2.2 Patient and HCP communication 
Different aspects of the HCP and patient interaction were studied to identify what characterised 
the communication, e.g. aspects discussed with the patients, questions asked by the patients, 
patients’ openness towards HCPs and patients’ understanding of information given by the HCP. 
 
Respondents identified adherence, nutrition and using condoms as the most important aspects to 
discuss with their patients. These three aspects were mentioned 26, 22 and 19 times respectively 
as shown in figure 6. 
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Figure 6: Health care professionals’ perception of the most important aspect to discuss with 
patients (n=55) 
 
The respondents were asked which of the topics from a list (question 4.7, appendix 3) that were 
discussed with their previous patient. The most frequently discussed topics mentioned by nurses 
and support staff were diet, supporter, protection and lifestyle. The next most frequently 
mentioned topics after these four aspects were: adverse effects for the nurses, and grant for the 
support staff. 
 
Patients and openness 
Off the interviewees, 69.1% reported that none of the patients had told them about concerns with 
regard to treatment or the disease during the previous seven days. Further, 14.5% of the 
interviewees reported that one patient had told them about such concerns, and 9.1% reported that 
two to five patients had told them about concerns during the previous seven days. For 1.8% of the 
respondents it was reported that “a few” patients had told them about concerns, and for the 
remaining 5.5% this question was not applicable. 
 
About half (54.5%) of the respondents reported that, during the previous seven days, patients had 
told them that they were more comfortable talking to one HCP than another. About half (45.5%) 
of the respondents also had the impression that patients were more open to one HCP than another 
because of the HCPs’ profession. Table 7 shows HCPs’ comments on patients’ openness, given 
during the interviews. 
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Table 7: HCPs’ personal comments on patients’ openness towards different categories of 
health care professionals 
Sometimes you can see that the patients are more likely to talk to a nurse. No patient 
has told that they prefer one HCP more than the other, but after they have left the 
doctor they might stop and ask the nurse something they didn’t understand. Maybe they 
are afraid of taking up too much of the doctor’s time. They know the doctors are busy 
and have to see many patients. 
Some patients are afraid to talk to the nurses because of their high profession. 
Some patients go straight to one of the CHW because they know them better. They 
[CHW] visit at home and feel that the CHWs are more like their friends. Then the CHW 
might refer them to the nurse. 
Some patients are less comfortable with the CHWs because they are afraid that the 
confidentiality is not kept as much. 
The patients are more open to CHW because they visit them at home. They are used to 
them and are more comfortable with them. 
 
Also factors other than the category of profession are seen to influence the patients’ openness to 
the HCP. These include trust, personality, language barriers, gender, personal relevance of 
knowing the HCP, personal skills and attitudes of HCPs. The diversity of the presumed 
influencing factors is shown in table 8, by the HCPs’ personal comments on this topic during the 
interview: 
 
Table 8: HCPs’ personal comments on influencing factors for patients’ openness 
Patients are not open to all, but want those involved in the ARV clinic. 
Ladies want to see lady HCPs, males want to see male HCPs. Think they are more open 
to nurses than to CHW. 
Patients are more open to those who show empathy. Personality is important, how 
concerned the worker is and how much the patient trust the worker. 
Patients can be shy in the beginning. One Afrikaans-speaking patient might have been 
more comfortable with an Afrikaans speaking worker. 
Who the patients are more open to is depending on personal skills and attitude. 
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Forty percent of the interviewees reported that none of the patients had asked any questions on 
their own initiative during the previous seven days. The frequency of patients asking questions is 
summarised in figure 7. When comparing support staff and nurses, 43.5% of support staff and 
42% of nursing staff reported that no patients had asked any questions. 13% of support staff and 
17% of nurses reported that a few patients had asked questions. The most frequently asked 
questions are shown in table 9. Comments from HCPs on why patients did not ask many 
questions are shown in table 10. 
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Figure 7: Frequency of patients asking questions during the previous seven days 
 
Table 9: Health care professionals reporting on questions frequently asked by patients 
Topic asked about Frequency 
Grant 63.6% 
Side effects 47.3% 
How to use medicines 29.1% 
Other 67.3% 
 
Topics less frequently asked about by patients, covered by “other” in table 7: 
1. About the treatment, about things they’ve heard/ how they will feel. 
2. Pregnancy/ breastfeeding/ PMTCT/ their children. 
3. About the illness, stage of disease and CD4 count. 
4. When to start treatment? How long they must take the medication? 
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5. Food parcels, nutrition. 
6. Why they need a supporter. What to do if they don’t have a supporter. 
7. Why they got HIV, where it came from. 
8.  Blood tests. 
 
Table 10: HCPs’ personal comments on why patients do not ask many questions 
Patients just accept how things are and don’t ask questions. 
Most aspects are covered in the counselling, so the patients don’t ask about this on their 
own initiative, but they often ask about grants. 
The patients generally don’t ask on their own initiative because they we about most things. 
The HCPs ask questions and tell everything of importance. 
Sometimes there is no time for patients to ask questions. 
 
Feedback from patients: 
When asked about the kind of feedback HCPs get from the patients to indicate if patients 
understand what they have been told, the most frequent responses can be classified into the 
following four categories, summarised in table 11. 
 
1. The HCPs ask the patients questions or ask them to repeat. The HCP can tell by what the 
patients answer. 
2. The HCP can tell from patients’ body language and facial expression. 
3. The HCPs report that they just know or can tell if patients understand. 
4. The HCPs can tell by asking if patients understand, or the patients tell that they 
understand. 
 
Table 11: Responses on the feedback HCPs get from patients (n=55) 
Category Frequency 
1  30 of the respondents 
2   19 of the respondents 
3   14 of the respondents 
4    6 of the respondents 
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Other responses on how the HCPs indicate the patients’ understanding of information given can 
be classified into (a) initiatives from the HCPs and (b) the patients’ actions. These are listed in 
table 12. 
 
Table 12: Basis for HCPs perception of patients’ understanding 
 
4.2.3 HIV treatment follow-up 
As elaborated in section 4.1.1, the patients are introduced to the treatment programme in their 
local clinics before initiation of ART. After patients are stabilised on treatment, the follow up is 
primarily done in the local clinic where patients meet with nurses and support staff for their 
monthly ARV collection and check up. Figure 8 summarises nurses and support staffs 
involvement in the following aspects of the treatment: repeating how to take medication, handing 
out medication and monitoring for adverse drug reactions and adherence daily. 
 Action/ initiative 
Initiative by the 
HCP 
Maintain eye contact. 
Give room for feedback. Give space to ask. 
Make sure the patients understand. 
Talk to the patients. 
Some patients are crying at first. HCP checks their state when they leave. 
Ask someone else to translate if language barrier. 
The HCP knows the patients. 
Can see when patients appreciate something. Can see if they’re anxious 
about something. 
Patients are enthusiastic when leaving. 
The HCP asks what she can do for the patient. 
Give very clear message. 
Action of patients Patients come back and say that advice was helpful. 
Patients express themselves well. 
The patients ask questions if they don’t understand. 
Patients may come back and ask about things they didn’t understand. 
Patients tell that they appreciated what the HCP has done. 
Positive response from the patients. 
The patients ask questions to clarify. 
Some patients come back and say that they are happy and have improved 
their health. 
The patients talk a lot. 
They respond and nod. 
Get feedback from most of them. 
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Figure 8: Nurses versus support staff in dealing with medication to HIV patients (n=55) 
 
Graph 8 shows that 75% of the nurses and 87% of support staff responded that they repeat to the 
patient how to take the medication. Off all the respondents, 16.4% reported that they did not 
repeat how to take the medication. 
 
About 30% of support staff handed out medication9 daily, while 45.8% of nurses handed out 
medication daily. Half (50.6%) of the support staff and 16.7% of nurses said that they never 
handed out medication to patients. 
 
Adverse effects 
As shown in figure 8, 58.3% of nurses and 39.1% of CHW monitored for adverse effects daily. 
The majority (76.4%) of all the interviewees reported that none of the patients had complained 
about symptoms of adverse effects during the previous seven days. Above 80% of both nurses 
and support staff reported that they had not received any complaints from patients during the 
previous seven days. Above 60% of the same groups reported that they had not met any patients 
during the previous seven days who received medication to treat symptoms of adverse effects. 
However, the pharmacist who was preparing medication for all the HIV patients collecting their 
medication in the different clinics estimated that about 30-40% of the patients received 
                                                 
9 either antibiotic prophylaxis or ARVs 
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medication to treat symptoms of adverse effects. One of the doctors estimated that 75% of the 
patients received medication for symptoms of adverse effects.  
 
Adherence 
As shown in figure 8, 58.3% and 56.5% of nurses and support staff monitored for adherence daily 
in their work with HIV patients. Table 13 shows the frequency of three different methods used to 
indicate adherence: pill count; asking questions and tick chart/medical diary. Pill count, which 
was reported most frequently, implies that the patients bring back the pill bags and the HCPs 
count how many tablets are left out. It was also mentioned by one of the respondents that the only 
way to get a more accurate indication of a patient’s adherence was to do blood tests. If the 
patients were adherent, the viral load should be low and CD4 count should be high. Blood tests 
were normally done every six months and could be done more frequently if the HCP suspected 
poor adherence. 
 
Table 13: Frequency of methods used to indicate patients’ adherence to ART by HCPs in 
Grahamstown’s public sector (n=55) 
Method for adherence indication Frequency % 
Pill count 69.1 
Ask questions 56.4 
Tick chart/ medical diary 43,6 
Other 9.1 
No method reported used 10.9 
 
Of all the respondents, 70.9% reported that none of the patients they had met during the previous 
seven days had told them that they had forgotten to take any of their medication. Table 14 shows 
the reports from the interviewees on the number of patients who had forgotten to take any of their 
medication during the previous seven days, and table 15 shows the reports on the number of 
patients who had told HCPs that they didn’t want to continue taking the medication. 25.5% of the 
respondents had the impression that some patients were unwilling to take their medication, 
regardless of what the patients had told them, while 72.8% of the respondents believed that none 
of their patients were unwilling to take their medication.  
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Table 14: Patients reported missed doses to HCPs during the previous seven days 
Number of patients forgetting 
to take any medication  
Frequency of response from HCP 
0 70.9% 
1 9.1% 
2 7.3% 
4 3.6% 
5 1.8% 
7 1.8% 
N/A 5.5% 
 
Table 15: Number of patients reported to HCPs during the previous seven days that they 
did not want to continue with medication (n=55) 
Number of patients not 
wanting to take medication 
Frequency or reported by HCP 
0 89.1% 
1 3.6% 
2 1.8% 
N/A 5.5% 
 
The respondents were asked about how often they had experienced that patients had 
misunderstood how to take the medication, and 65.5% of the respondents reported that they had 
not met any patients during the previous seven days who had misunderstood how to take their 
medication. It was reported by 25.5% of the interviewees that they had met one to four patients 
during the previous seven days who had misunderstood how to take the medication.  
 
Use of traditional medication was mentioned as a possible reason for patients not wanting to take 
their medication, and therefore not being adherent. Opinions from group discussions were that 
stigma had not been as problematic as first expected, though HCPs from down referral clinics 
pointed out that many patients had problems with disclosure and were afraid of being stigmatised. 
Respondents report that patients were generally more afraid of ARVs in the beginning because of 
things they had heard about the treatment. 
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4.2.4 Health Care Professional cooperation 
4.2.4.1 Communication between HCPs 
The respondents were asked who they confirmed with if the patients were complaining about 
symptoms of adverse effects. Of the support staff, 91.3% reported that they would confirm with a 
nurse, and 87.5% of the nurses reported that they would confirm with a doctor. Figure 9 shows 
the number of times that nurses and support staff asked other HCPs for advice during the 
previous seven days while a patient was waiting. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Nurses versus support staff in asking for advice (n=55) 
 
Half of all the respondents (49.1%) had not asked for advice while dealing with a patient during 
the previous seven days, 40% of the HCPs had asked for advice one to five times and 1.8% of the 
respondents asked for advice daily. 
 
Table 16 shows the frequency of the participation in HCP interactions, varying from informal 
discussions about the patients to scheduled weekly meetings with other HCPs. One-third of the 
nurses had participated in meetings during the previous seven days due to their work with HIV 
patients. 
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Table 16: Health care professionals discussing of patient cases (n=55) 
Type of HCP cooperation: Frequency 
Discuss patient case while patient is waiting: 85.5 
Discuss patient case after patient has left 87.3 
Review meeting, Settlers Hospital 41.8 
ARV clinic Friday meeting 18.2 
Ward round, Settlers Hospital 10.9 
ARV task team meeting 32.7 
Attended scheduled meetings during previous seven days due 
to work with HIV patients 
27.3 
 
The respondents who reported that they sometimes discussed difficult patient cases with 
colleagues were asked to quantify how many times during the previous seven days they had 
discussed such a case. Table 17 shows the frequency of such discussions reported by the HCPs: 
 
Table 17: Frequency of discussing difficult patient cases with colleagues during the previous 
seven days (n=55) 
Frequency of discussions Percentage of HCPs 
0 41.8% 
1-4 47.2% 
Daily 5.5% 
Many 1.8% 
Most of them 1.8% 
N/A 1.8% 
 
4.2.4.2 Referring of patients: 
It was reported by 33 of the 55 HCPs that they had done one or more referrals due to problems of 
a kind that was beyond the HCPs’ competence during the previous seven days. Of these 
respondents, 25 were HCPs working in down referral clinics. Of a total number of 45 respondents 
from down referral clinics, 20 reported that they had not made any referrals during the previous 
seven days. Fourteen of the respondents who reported they had made referrals reported that they 
had referred patients due to medical issues. The most frequent reason for referral of patients was 
social problems, reported by 29.1% of the respondents. Table 18 shows the most frequent reasons 
for referrals done during the previous seven days for the day of the interview. 
 
 41 
Table 18: Frequency of referrals (n=55) 
 Frequency 
Social issues 29.1% 
Disease progress 25.5% 
Adverse effects 23.6% 
Poor adherence 16.4% 
Diet 10.9% 
Other 29.1% 
 
Sixteen of the respondents (29.1%) were either unable to classify the reason for the referral, or 
they had referred patients due to problems not covered by the five categories listed in table 18. Of 
the 16 open-ended responses obtained, two respondents highlighted weight changes and two 
referred to shingles as the reason for referrals. Patients were also referred to the antenatal clinic if 
found pregnant or to the gynaecologist because of lesions. Among the other reasons highlighted 
were: sickness, co-existing HIV and tuberculosis, septic leg, bleeding when urinating and 
dehydration. One of the important aspects highlighted by a respondent was that patients were 
referred to Raphael Centre for VCT because public sector clinics at times were too busy. Raphael 
Centre is a Non-Governmental Organisation (NGO) providing VCT for free to people in 
Grahamstown. 
 
4.3 Workload 
The HCPs were asked how many patients they had met for VCT and follow-up during the 
previous seven days. Table 19 shows the results. 
 
Table 19: Number of patients seen during the previous seven days (n=55) 
Number of patients seen VCT Follow up 
0-10 69.1%  65.5% 
11-20 18.2%  12.7% 
30 0 3.6% 
65-120 0 11% 
N/A 9.1%  1.8% 
O/A 1.8% 3.6% 
Missing answer 1.8% 1.8% 
 
All six HCPs who reported meeting 65 patients or more during the previous seven days were 
from the referring site where they normally have 25-30 HIV patients coming daily. Thirteen 
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(23.6%) of all the interviewees were occupied with HIV-related work full time. Time pressure as 
a limitation in the work was acknowledged by 75% of the nurses and by 62.5% of support staff. 
Most of the nurses (91.7%) and more than half (65.2%) of support staff reported that they made 
priorities in their work with HIV patients due to time shortage. Comments on workload given by 
the HCPs during the interview are shown in table 20. 
 
Table 20: Personal comments on workload 
Because of other duties that have to be done, less time is spent with HIV patients. 
Someone else must do more of the work with HIV patient. If someone else did some of the 
work with HIV patients they will be asked later if there were any problems. 
There are too many patients, and patients have too little knowledge. There is too much to 
talk about for one meeting. 
Because of too many formal things I can’t participate in meetings anymore. They will call 
for me if they need me. 
The work is not limited because of time shortage, but I am tired because of the workload. 
If time is too short, home-visits are done after work or during weekends. 
There is not enough time for counselling. I’m rushing the administration stuff. 
Time shortage limits the work with other patients who must wait. 
HIV related problems take time and lower the pace of patient intake. 
I was supposed to attend a patient review meeting but had to ask someone from a different 
clinic to present because of staff shortage. 
 
Waiting time 
Waiting time for HIV patients depended on factors like the patient’s reason for the visit, the 
treatment facility’s queuing system, time of the day, and unpredictable variables like patient load 
and the clinic’s capacity each day. In some treatment facilities, the HIV patients were separated 
from other patients and did not wait in line. In some clinics the HIV patients were categorised as 
“first line” or “priority” patients, or were separated from other patients only for particular 
purposes, e.g. VCT and ARV collection. In other clinics the staff reported that HIV patients 
queued with all other patients. Some of the treatment facilities had a special nurse for HIV 
patients. Table 21 summarises the HCPs’ responses to HIV patients’ waiting time in their clinic. 
Observations showed that waiting time was sometimes used to educate patients either by use of 
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video or a health educator talking to the patients. Personal comments from HCPs on waiting time 
are listed in table 22. 
 
Table 21: HIV patients’ waiting time in Grahamstown’s public health care facilities (n=55) 
Waiting time Frequency 
Minimal 45.5% 
10-30 min 20% 
35-60 min 5.5% 
> 60 min 3.6% 
Open-ended answers 20% 
Difficult to quantify 3.6% 
Response missing 1.8% 
 
Table 22: Personal comment on waiting time given during interview 
HIV patients don’t wait. We have a sister for only HIV patients 
Waiting time depends on the day. Sometimes it is 5-10 minutes until the sister finishes 
with the other client. ARV patients go straight because they are first line patients if they 
have come for ARV collection. Collection can be very quick so we don’t want them to wait 
with the others patients. 
Patients don’t wait for the doctor, only if there is another client. They wait long for 
medication. If they don’t get the medication before lunch time they might not be ready to 
leave the clinic until 4-5 hours after they arrived 
Don’t know the average waiting time. Sometimes it’s short. It depends on the day and 
how many staff and patients. HIV patients queue with all the other patients. We don’t 
separate the lines because then others can see that there is something special with these 
patients. 
 
Problems not dealt with in the health facility 
More than 60% of the respondents reported that there sometimes were important issues that could 
not dealt with before the patients left the health facility. This was due to either time constraints or 
problems that could not be dealt with by HCPs in the clinic. Some of the issues that could not be 
dealt with straight away were: social problems, delay of treatment initiation due to problems with 
disclosure and patients having problems with their economy. Sometimes the HCPs had to ask 
patients to return later for the blood test if there was a staff shortage or if the blood samples had 
already been collected for the day. HCPs personal comments on problems not dealt with are 
shown in table 23.
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Table 23: Personal comments from HCPs on problems not dealt with in the health care 
facility 
A problem if patient has not disclosed but wants to be put on treatment programme. Need 
to counsel. The procedure followed for treatment initiation says that the patient must 
have supporter. 
If a patient has financial problems but can’t get grant because CD4 count is too high. Can 
organise clothes for the patient, but not food. Only patients who have CD4 count less than 
200 and disease stage 3 or 4 can get grant. The grant takes long to organise. 
 
Patients with special needs 
When the HCPs were asked if they had met HIV-positive patients in need of special help, 83.6% 
of the respondents could specify such situations. Frequently mentioned problems were regarding 
money, food and support from family. Comments from the HCPs are shown in table 24. 
 
Table 24: Personal comments from HCPs on patients’ problems 
Most common problems are food and money 
Most of the patients have financial problems and suffer from lack of support. E.g. the wife 
doesn’t want the husband to know about the HIV status, so we must do the visits other 
places than at home. 
Problems at home with no support from family 
 
4.4 Training of HCPs 
All the respondents reported that they thought specific training was required for their work with 
HIV patients, and 81.1% had received some kind of training. However, the training they had 
undergone varied to a great extent from work shops and training by colleagues in the clinic for 
some HCPs to a semester or a one year’s course for other HCPs. Twelve respondents reported 
that they had participated in workshops, and for six of these this was the only training they had 
been provided. Table 25 shows the number of respondents who reported that they had received 
training in any of the following topics: ARVs, counselling, testing or training on HIV. Table 26 
shows how many days of training the HCPs had been provided with in the different topics. 
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Table 25: Training of health care professionals in Grahamstown’s public sector (n=55) 
Topic: Percentage of HCPs 
ARV training 36,4 
Counselling 70,9 
Testing 27,3 
HIV/AIDS 12,7 
 
Table 26: Amount and kind of training provided for HCPs working with HIV patients in 
public sector in Grahamstown (n=55) 
Topic Number of 
respondents 
with training 
How many who could 
quantify amount of 
training in days 
Training two 
weeks or 
more 
Training 
less than 
two weeks 
In-
services 
training 
Counselling 39 13/39 9/39 4/39 0 
ARV 20 10/20 3/30 7/30 0 
VCT 9 9/9 6/9 2/9 1/9 
HIV/AIDS 7 3/7 1/7 2/7 0 
PMTCT 6 5/6 1/6 4/6 0 
Testing 2 2/2 0 1/2 1/2 
 
Other topics of training that were mentioned included: home base, palliative care for people 
living with HIV/AIDS, nutrition, couple counselling and sexually transmitted diseases. 
 
4.5 Preparing for and launching the HIV treatment programme in Makana 
district 
 
The information in this section was gathered from the two group discussions conducted. 
 
The process of planning the treatment programme in Makana district started in December 2003, 
five months prior to the rollout in Grahamstown. Site accreditation was based on the hospital’s 
capacity, population estimates and needs in the community. Grahamstown fulfilled the criteria 
and Settlers Hospital applied for accreditation when they were informed about the national 
programme. When Settlers Hospital became accredited they were directed to initiate the 
programme without further recruitment of staff. At the time of preparation any reference point 
regarding initiation of the treatment programme and maximum enrolment of patients annually did 
not exist. A multidisciplinary team was set up for Makana district and weekly meetings were held 
to prepare for the roll out. The Makana task team included doctors, nurses, Settlers Hospital 
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management, Settlers Hospital dispensary, representatives from Makana Municipality, PHC 
clinical nurses, representatives from non-governmental and community based organisations. 
Cooperation with the private sector was not established at this stage. 
 
Initially the idea was to initiate the treatment for the patients in the local clinics, but this was 
changed to preparing the patients in the clinics and initiate treatment at Settlers Hospital. 
Ensuring sufficient space in the health care facilities for patient counselling and check-ups were 
important aspects of the preparations. The national guidelines were adapted, and some 
cumbersome forms were simplified by one of the doctors in the task team.  
 
Three days of training in comprehensive HIV management was provided by the Regional 
Training Centre, and it was reported that training had mainly consisted of self-training after this. 
There was a frequent need for training, due to the constant turn over in staff. CHWs were trained 
by a doctor and a social worker to do home visits for HIV patients on the. One of the participants 
pointed out that Grahamstown was one of the few treatment sites where the social assessment 
was still done. In order to optimise the relationship between patient and HCP, home visits were 
done by both a social worker and CHWs. 
 
Six months after the initiation of the rollout, Settlers Hospital was provided with a doctor, 
programme manager and social worker. Extra staff had been provided to the down referral 
clinics. The HIV specialist clinic, Masunwabe Clinic, was established at Settlers Hospital in May 
2005. To facilitate the work a paediatric clinic that operated once a week had been started. 
 
According to participants in the group discussions, communication between referring hospital 
and the clinics was good, and every Wednesday there was a review meeting with staff from 
Masunwabe clinic from the down referral clinics to select new patients. One of the participants 
commented that the HCPs’ teamwork had been a great advantage for the treatment programme. 
Participants pointed out that the provinces set yearly targets and the target for 2006 was already 
met by August 2006. It was also emphasised that the launch of the programme happened without 
intensive preparations for the programme. The rapidity was exemplified by the fact the one of the 
members was not aware of which medication was to be used for treatment.  
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Participants also reported that some of the difficulties experienced were problems with sick 
patients who were started on treatment with ARVs in the hospital. The patient readiness 
programme for these patients has been speeded up, and when their medical condition allows them 
to be discharged some of these patients did not return for follow-up. 
 
Steps taken to ease the pressure at Settlers Hospital 
By September 2006, 687 patients had been enrolled on the ART programme, and the system was 
operating at its maximum. Since the treatment programme was initiated, 210 patients had been 
down referred to clinics and 52 patients had died while on treatment. The remaining patients were 
in their stabilising stage, receiving medication at Settlers Hospital. To distribute some of the 
workload of Settlers Hospital, Settlers Day Hospital managed all chronic out-patients. Settlers 
Day Hospital had recently been accredited as treatment site for the ART programme to allow for 
expanding of the programme.  
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5 Discussion 
5.1 Material 
Though the presented study was a project in social pharmacy, focus was on the role of all 
different HCPs providing treatment and follow-up of HIV patients in Grahamstown’s public 
sector. Only two pharmacists were involved in this work on regular basis, and therefore it was not 
possible to study only the role of the pharmacist. Due to the limited number of HCPs in 
Grahamstown’s public sector, it was desirable to include all HCPs from each category of HCPs 
involved in this work for structured interviews. 
 
Three methods were used in this study: observational studies, semi-structured interviews and 
group discussions. 
 
5.2 Method 
5.2.1 Choice of method 
Observation as a research method can have varying degrees of participation, and is a common 
used technique for data collection. Observation can give additional and more accurate 
information about people’s behaviour than interviews, and is especially good for assessing the 
quality of care in health centres and hospitals [52]. For this study it was desirable to gather 
information about the overall work and roles of different HCPs before the questionnaire was 
constructed and the interviews were conducted.  
 
Interviews as a method can have varying degree of flexibility, and in this study it was used semi 
structured interviews. Less flexible methods, like structured interviews, are useful when the 
researcher is relatively knowledgeable about expected answers [52]. A limitation to the 
questionnaire is that the design was based on information gathered from observation at health 
facilities in town or very close to the town centre only and the researcher did not have an overall 
picture of the whole span including clinics from the more extended areas of Grahamstown. 
However, this was presumed to not cause a major source of error, since all HCPs operated 
according to the same guidelines for ART, and it was already identified from weekly meetings 
that HCPs from the different clinics interact and cooperate frequently. 
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It was decided to conduct two discussion groups, since information about the preparation and 
launching process of the ART programme could not be gathered from the respondents for the 
questionnaire, nor could such information be gathered from the observational studies. 
 
5.2.2 The interviewing process 
The clinics faced unpredictable days with regard to workload and time pressure due to 
emergencies, bigger patient loads than expected or staff shortage, so many of the appointments 
had to be rescheduled when arriving for the intended interview. Some of the respondents 
preferred to make a specific appointment, whereas other respondents could not specify further 
than “morning” or “afternoon”. Due to these unpredictable occurrences the interviewing process 
was at times laborious and a high degree of flexibility was necessary to adjust to the respondents’ 
schedules. 
 
5.2.3 Validity and reliability 
“Validity refers to the degree to which scientific observations actually measure or record what 
they purpose to measure” and “reliability refers to the repeatability of scientific observations”. 
[52] A threat to the validity of this study is the possibility that respondents might have felt that 
they had answer, or answered what they thought the researcher wanted to hear. Another factor 
which may have affected the validity in this study is the language, since English was not the first 
language for neither the researcher, or for the majority of the respondents. The same 
questionnaire was used for all HCPs and despite effort to design widely understandable questions 
the varying educational backgrounds might have resulted in different perceptions of the 
questions. It increases the validity that all HCPs agreed to participate, and all interviews were 
conducted by one researcher. 
 
The questionnaire was designed for the purpose of conducting operational research on the ART 
programme in Grahamstown, and not to study people’s opinions on a specific topic. When 
studying people’s opinions, the questionnaire can be tested with regard to reliability and validity 
by cross-checking the responses to different questions for the same respondent. The questionnaire 
for this study was not eligible for such tests. 
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The sample size cannot be greater than the total number of people who are involved in the 
specific area of investigation. Even if this is a necessary limitation of this study, it should not 
make it less important to investigate the operating system. All HCPs who were asked agreed to 
participate, which makes the impact of this limitation as small as possible.  
 
5.3 Results 
5.3.1 Role of pharmacists in ART programmes 
The focus of this study was the role of different health care professionals in treatment and follow 
up of HIV patients in the public sector in a setting where resources are limited. Results of this 
study showed that there were few pharmacists involved in the ART programme, and they 
interacted with patients only to a limited extent. Nurses and support staff were carrying out work 
tasks that, according to WHO’s descriptions of the roles of the pharmacist, ideally should be the 
responsibility of pharmacists. Therefore, the ideal responsibilities of the pharmacists will be 
discussed briefly before the discussion of the roles of other HCPs in this treatment programme. 
This is to point out clearly some of the consequences of a system with constrained resources 
regarding economy and HCPs with a high educational background.  
 
The roles of a pharmacist in health care are summarised in the “seven star pharmacist” by WHO 
consultative group 1997. The seven roles include: care giver; decision maker; communicator; 
leader; manager; life-long learner and teacher [53]. According to the WHO consultative group, 
the pharmacist should provide caring services and be comfortable with interacting both with other 
HCPs and the public. The pharmacist should assume a leadership role and be responsible for 
cost-effective use of resources and for sharing information about medicines. With regard to work 
with an HIV treatment programme, these roles would naturally imply dispensing medicines and 
sharing information about ARVs to patients and HCPs and patients’ adherence monitoring and 
training. The presented study showed that dispensing ARVs was the responsibility of the 
pharmacist, but in all clinics except one, ARVs were handed out to the patients by nurses. Nurses 
were also responsible for training and monitoring of adherence, monitoring of adverse effects and 
educating the patient about the ARVs. 
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5.3.2 Down referral treatment structure  
The ART programme in Grahamstown was based on follow up at PHC level. This is according to 
directions in the Operational Plan that PHC clinics and community health centres are primary 
sites for diagnosis, staging and routine follow-up of HIV-positive patients. It says further that 
these sites will provide the majority of ARV adherence monitoring and support, and only when 
appropriate expertise exists can ART be initiated at primary and community level.  
 
Research has shown that PHC-based systems, where PHC clinics offer first-level care, only work 
effectively if the clinics can deal with 80% of health care problems in the population and 
therefore reduce the pressure on hospitals [22]. The treatment programme in Grahamstown was 
still in an early stage, after implementation in May 2004 and results from the study showed that 
the major patient load was in the stabilising stage, receiving medication at Settlers Hospital. To 
what extent the health care-related problems among HIV patients were truly dealt with within the 
PHC clinics was not studied sufficiently to say whether or not they were dealing with the 80% of 
the problems that the above-mentioned research says is necessary for the system to work 
effectively. However, only approximately half of the respondents from down referral clinics 
reported that they had made referrals during the previous seven days, and about half of these 
respondents reported referrals related to disease progress, poor adherence, or adverse effects. This 
indicates that the clinics could deal with the majority of health-related problems that HIV patients 
presented with.  
 
It has been stated that primary health care services are generally associated with improved health 
status, and that increased focus on this is required [54]. In order to deal with the majority of 
health care problems at PHC level, competent and skilled HCPs are required. The challenge in 
this work was acknowledged by the HCPs involved, who called for more training. By directing 
much of the time-consuming work to the PHC clinics, the burden on the local hospital was 
decreased, but this had put a pressure on the PHC clinics. The results of this study showed that 
support staff played a major role in treatment and follow up of HIV patients. This structure is in 
line with recommendations from Médecins Sans Frontières (MSF), to involve a broad spectre of 
contributors in treatment and healthcare. The recommendations are based on MSF’s work in, 
among other countries, South Africa [29].  
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Studies by WHO in other countries in Africa show that different approaches have been adopted 
when initiating an ART programme. Botswana was the first country in Africa to provide a public 
ART clinic in 2001, and the country has often been referred to as an example to others [55]. PHC 
clinics in Botswana that provide preventive therapy, treatment for tuberculosis, social services 
and routine medical care were initially not used for provision of ART. The aim is now to 
decentralise the ART so that patients can receive comprehensive care at one clinic. It is also 
suggested in an article on lessons learned from the establishment of the ART programme in 
Botswana that experienced nurses should play a key role in caring for stable patients receiving 
ART [56]. 
 
In Chiradzulu, Malawi, the initial design of the ART programme in 2001 also required all 
patients to begin therapy at hospital-based HIV clinics, and some patients were referred to clinics 
closer to their homes. This structure changed in 2002 to HIV clinics run at health facilities instead 
of exclusively at hospitals, and the intention is to transform the hospital into a referral centre in 
order to increase patient numbers [33]. 
 
The above-mentioned studies show that other treatment programmes that initially started with 
centralised hospital-based HIV clinics for follow up of HIV patients are adopting the structure 
that exists in Grahamstown’s public sector. This implies that the benefits in including PHC 
clinics in this work have been acknowledged by decision makers in these countries. An article on 
access to ART in Africa also highlights that providing treatment in central hospitals without 
strong links to community outreach or PHC services weakens the link between prevention and 
care [57]. 
 
5.3.2.1 Facilitating and constraining factors in the treatment structure in Grahamstown 
VCT done at the local clinic is convenient for the patients, and it is advantageous that results 
from the test were given on the same day as the counselling and testing took place, as the patient 
would get the results immediately. The same HCP did both pre- and post-test counselling which 
is good for the patient/HCP relationship. This way of organising the work is potentially resource 
efficient since all the preparing work was done by CHW, CCW and registered nurses. Ideally 
only HCPs who had gone through training would do the specific tasks, this would ensure a 
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certain level of competence among the HCPs involved. However, the results from the study 
showed that the amount and kind of training received varied a lot, therefore it was difficult to 
generalise the level of competence for the HCPs involved.  
 
It was a facilitating factor in this system that HCPs could visit patients at home to identify factors 
influencing the patient’s ability to cope with the treatment and the disease. Patients with special 
needs could be identified during the home visit. The HCP who did home visits had gone through 
specific training and also used a standardised scheme to document the findings. Using a 
standardised scheme increases the reliability of the information gathered, as all HCPs then would 
ideally collect the same information about the patient’s social and economical situation.  
 
The first stage when the doctor was involved in discussion about the patient case was when the 
patient was eligible and ready for treatment, and the nurse presented the case at the review 
meeting at Settlers Hospital. A team of different HCPs met weekly to discuss whether patients 
were to be enrolled on the programme. Though respondents reported that they did not always 
have time for the review meeting, results showed that this meeting served as a regularly gathering 
point for HCPs from different clinics. A report on the treatment programme run by MSF in 
Chiradzulu, Malawi, shows that that this programme initially had a similar committee for 
selection of patients. However, this arrangement was disbanded as a step to increase patient 
numbers a year after the programme was initiated [58].  
   
That patients in Grahamstown were stabilised on treatment before down referral to the PHC 
clinics ensures that prospective complications occurring at an early stage would be identified by 
HCPs with the highest competence available in the system. At Settlers Hospital only one 
pharmacist was available to prepare medication for all the patients, and the workload was heavy. 
Due to the workload the pharmacist’s work tasks were limited to mainly dispensing and 
recording, without direct patient contact. There were only two doctors who worked specifically 
with the ART programme. 
 
One of the strengths of the system was that patients did not use the doctors time unless it was 
necessary. Stable patients came to their local clinic for all issues and sicker patients were 
 54 
prioritised for doctor appointments. A potentially weak point is that patients had to go via the 
clinic if they were very ill.  
 
It is the intention of the Operational Plan that integration of HIV- and AIDS-related services into 
existing systems at the primary care level reinforces the national strategy for primary health care 
[20]. According to the Operational Plan, the patients should receive counselling, nutritional 
assistance, psychosocial support and appropriate social welfare evaluation where necessary. 
Results from the study showed that patients were provided with counselling. Counselling was the 
most frequent topic of training received, reported by 70% of the respondents. Nutrition was one 
of the issues that HCPs thought were the most important to discuss, mentioned by 22 of 55 
respondents. Social support was the most frequent reason for referring of patients to other HCPs. 
This shows that the ART programme operated according to aims in the Operational Plan. Results 
also showed that patients on the ART programme in Grahamstown are provided with a drug 
readiness programme, according to requirements in the Operations Plan.  
 
The structure of the treatment programme in Grahamstown and use of HCPs corresponded to a 
recommendations in a WHO report on overcoming constraints in a public approach to ART. The 
report emphasises the importance of making optimal use of human resources and highlights the 
need for delegating routine aspects of managing treatment and care to other health care workers 
as one such strategy. WHO reports that physicians should play a lead role in assessing people 
living with HIV/AIDS, initiating or switching therapy, managing serious conditions and 
supervising staff. Clinical officers, nurses and counsellors will routinely follow up ART [33].  
 
Equity in access to ART was ensured by a “first come, first serve” structure. Equity challenges 
and how resources should be allocated are elaborated in and article on access to ART in Africa. It 
is stated that in a health sector that suffers from lack of resources and underdevelopment, 
providing treatment on a “first come, first served” system favours urban, higher educated people 
who are not poor, and that it unfairly leaves decisions about who will receive treatment on the 
health care workers [57]. It is also emphasised in the article that CHWs have had an important 
role in Africa in many health-enhancing interventions, and that developing their role in access to 
treatment could strengthen primary health care and should be further explored. The results from 
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this study showed that in general all patients who approached for testing and follow up were dealt 
with at the clinic. However, in times of understaffing and heavy workloads, patients were referred 
to other facilities. According to respondents from the discussion groups, the system was operating 
at its maximum, and initiative was taken to facilitate expansion of the treatment programme by 
accreditation of Settlers Day Hospital as a new treatment initiating facility in the ART 
programme in Grahamstown.  
 
5.3.2.2 HCP cooperation in the treatment programme 
According to the Operation Plan, there should be ongoing communication between the primary 
health care facility and district hospital HIV/AIDS specialty clinic to ensure that patients are seen 
and monitored according to national treatment guidelines [20]. It has been stated that “a 
functional referral system involve communication between providers and agencies involved in 
patient care to maximise the quality and effectiveness of those services” [59]. The opinions of the 
discussion groups were that communication between the local clinics and the hospital was good, 
and teamwork had been an advantage. Many of the HCPs met weekly to discuss patient cases. 
60% of the HCPs had referred patients to other HCPs during the previous week, and HCPs 
interacted and communicated actively with each other for the patients’ benefit. 
 
Clinic meetings were generally held weekly at the health care facilities. In the PHC clinics there 
was no separate time for HIV cases, so time available for discussions was divided between all 
issues dealt with in the clinic. CHW and CCW reported back to nurses after home visits, but 
further studies are needed to identify the information reported back to the nurses. Over 85% of 
the HCPs reported that they had discussed patient cases among them, but only about half of the 
respondents reported that they had asked colleagues for advice during the previous seven days. 
Communication within the health care facilities was facilitated by HCPs working in close 
proximity to each other. The results showed that HCPs had intern training with HCPs who have 
not received training. This indicates that there was cooperation among the HCPs, and motivation 
to learn from each other. 
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5.3.3 Patient education, care and follow-up 
Since time available with a patient is limited, the way this time is spent is crucial for the quality 
of health care provided. The time available needs to cover monitoring of adverse effects, 
adherence monitoring, health-check, social aspects of the patient’s life, and regular blood tests.  
 
5.3.3.1 Patient education 
In this study it was found that the responses to the question about counselling of patients starting 
on ARVs were not uniform. A standard answer was expected, but the respondents had different 
perceptions of what “counselling of patients starting on ARVs” meant. Some respondents said 
that they didn’t counsel patients starting on ARVs because this was done at the referring site 
when patients were initiated on treatment, while their colleagues said that they did such 
counselling and referred to their preparing of patients in the clinic before they were sent to 
Settlers Hospital. The observational studies showed that patients were prepared in general for the 
medication in the clinic, but not until the patients came to Settlers Hospital for treatment 
initiation did they receive counselling based on the exact treatment and dosage prescribed. 
Different HCPs were involved at different stages with regard to patient education. This can have 
different outcomes, for example patients might receive a lot of information repeatedly and so 
understand it thoroughly. It was acknowledged by respondents that it was a lot of new 
information for the patient in the beginning, so repetition might be necessary. Another outcome is 
that HCPs might feel less responsible for the patient education since information will be repeated 
by other HCPs later. Combined with the existing time pressure at all levels in the system it can be 
argued that this could lead to patients receiving insufficient information. The results showed that 
some HCPs did not talk to the patients about the treatment because other HCPs would talk to the 
patient about this later. 
 
5.3.3.2 Treatment follow-up 
Follow up includes counselling, screening after testing HIV-positive, home visits, adherence 
training with antibiotic prophylaxis, CD4 and viral load monitoring, examination, ARV initiation 
and ARV collection monthly. Except for the period when patients were stabilised on treatment at 
Settlers Hospital, follow up was mainly done by nurses and support staff in the local primary 
health care clinics. The findings show that patients generally did not have appointments. Patients 
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were given appointments for ARV collection, but were encouraged to come back to the clinic if 
they experienced any problems. Though such degree of flexibility might make it difficult to plan 
the days in the clinics, this was accounted for by providing different programmes on fixed days, 
and thereby maintaining a structure. On the other hand, the results showed that it was a necessity 
for patients to come on certain days for ARV collection in order to always have sufficient 
medication, and to facilitate adherence monitoring.  
 
The results showed that it had been a problem that some patients did not come for follow up after 
testing HIV positive. HCPs’ views on why patients failed to come back for follow up were 
among others poor disclosure, use of traditional medication, or that the urgent need to start 
treatment had not allowed for a sufficient patient readiness programme. 
 
Individualised care 
Results of the study showed that patients had different needs and problems. These were among 
others lack of support and care from family, inability to take care of themselves, difficulties with 
cleaning and cooking, alcohol abuse problems, and lack of food and money. HCPs did a variety 
of different tasks and prioritised what they included in their work. A study on health literacy and 
health-related knowledge among people living with HIV/AIDS highlights that patients are a 
diverse group with varying skills and knowledge, regardless of race or country. It was 
emphasised in the study that this is a challenge for the HCPs and is also relevant and important to 
consider when determining follow up procedures and implementing a treatment programme in a 
health care unit. Previous research has shown that patients of lower health literacy are less likely 
to have an undetectable viral load, and are less likely to know their CD4 count and viral load. 
Lower health literacy is also related to misperceptions that anti-HIV treatments reduce the risk 
for sexually transmitting HIV, and beliefs that anti-HIV treatment can relax safer-sex practices 
[60]. Considering these findings from other research on health literacy, it is likely that making 
assumptions about patients’ knowledge, understanding and commitment can lead to incorrect 
generalisations about patients and in turn insufficient follow-up of patients. Although results 
showed that many of the HCPs in Grahamstown had good knowledge about their patients, as 
previous research has shown, HIV patients make a diverse group and therefore have different 
needs with regard to follow up and education. One of the actions taken that served to minimise 
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false conclusions about the patients in this system was the social assessment done prior to ART 
initiation. This contributed to achieving an understanding of each individual’s situation and the 
patients’ different needs. Another facilitating factor in this treatment system for individualised 
care was that almost 80% of the respondents reported that they recognised all or most of the 
patients. It was reported that patients with special problems could be referred to social worker or 
hospice. 
 
HCPs involved in the work 
Results showed that all HCPs were South African, and most of them could communicate in the 
patient’s first language. Many of the respondents reported that they saw the patients around in the 
area where they lived, which gave a more complete picture of the patients’ lives and situation. 
Knowing the culture and the language is a facilitating factor for good communication between 
patient and HCP, and for the patients to be as open as possible. 
 
Results showed that nurses and support staff counted for almost 90% of HCPs involved in the 
work with HIV patients. As highlighted earlier there is a high degree of HCP migration from 
South Africa, lack of educated HCPs and lack of economic resources. It has been emphasised 
several times in literature that CHWs play an important role in provision of health care, and 
results from this study support these statements. CHWs, especially, met patients in their home 
sphere, and could therefore gain an overall picture of the patient’s situation. WHO has defined 
health as "a state of complete physical, mental and social well-being and not merely the absence 
of disease or infirmity" [61]. This means that patients are not only in need for HCPs with 
competence on their medical condition, but also need someone to know their social condition. If 
trained well, the CHWs can fill a dual role by caring for the patients’ medical problems and by 
doing social assessment. 
  
Only five men were directly involved in the work with HIV patients in Grahamstown’s public 
sector, and not all the down referral clinics had male HCPs. This is a possible constraint in the 
system since one of the factors reported necessary for patients’ openness was that patients might 
wish to be seen by a HCP of same gender, and 30% of the patients enrolled on the programme are 
males. This may put a lot of pressure on the few male HCPs, and if capacity is too low it may 
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result in some patients not being seen by their preferred HCP. To what extent the communication 
and follow up was constrained by the factor that patients were not seen by the HCP they were 
most comfortable with, needs to be investigated further.  
 
Time spent with patients 
Time spent by HCPs with the patient varies among different professions and is different for first-
time visits and follow-up visits. The higher the level of education, the fewer health care 
professionals are involved in the treatment programme, and the less time is spent with the 
patients. This shows that it is important to train all HCPs well, especially those who have less 
health-related educational background, since they are the ones who in general spend the most 
time with patients. More time is spent during the first visit, when the patients receive a lot of new 
information. In this situation it is possible that the patients initially do not have so many 
questions, but are more concerned about listening to information given. 
 
Communication with the patients 
The HCPs reported that the most important issues to talk about were adherence, nutrition and 
protection. At the same time it was reported that what patients asked about most frequently was 
the disability grant. Results showed that the HIV patients often had special needs, and often 
required special help both with regard to medical and social issues. Patients using public 
treatment facilities are those who cannot afford medical scheme and these patients often have 
problems with food and money. This could explain why the most frequently asked question by 
patients is about the disability grant.  
 
There was a split opinion on how much the patients ask questions. Some report that patients ask 
questions daily, while others report that patients generally don’t ask questions. At the same time 
most of the HCPs had the opinion that the patients were open to them and they based their 
assumptions on the patients’ trust. Results showed that some HCPs had the impression that the 
patient counselling was so thorough that patients did not ask on their own initiative. Such 
statements do not acknowledge the possibility that there may be things of importance to the 
patient that were not covered by what the HCPs saw as important.  
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In the study a general opinion was not found on which category of HCPs the patients were more 
open to. The general pattern that was found was that most of the HCPs thought patients were 
open to them and their group of HCPs. However, it was also mentioned by both some CHWs and 
some of the nurses that some patients were afraid of talking to the CHWs because they were 
worried that confidentiality was not kept. Another respondent commented further that this had 
been a problem earlier, but that it was better at the moment. It is very important that the patients 
can trust the HCPs they are interacting with so that they are open about problems and in turn 
receive the health care that they need. Other factors that were seen to influence the patients’ 
openness were HCPs’ personal skills, who the patient had disclosed to in the clinic, gender, and 
how much the patient trusted the HCPs.  
 
HCPs working on this treatment programme generally knew their patients well. This is to both 
the patients’ and HCPs’ benefit and facilitates good health care and follow-up as many decisions 
made were based on trusting the patient. The results also showed that because they knew their 
patients well the HCPs noticed that patients were not always honest. However, results show that 
not all HCPs knew the patient as well, and therefore not all HCPs involved would notice if the 
patients lied.  
 
Feedback from patients 
The information from patients that HCPs based their assumption and decisions about the patients 
on included both passive and active feedback from the patient. Some report that the patients 
asked questions if they did not understand; some HCPs asked patients to repeat. Some HCPs 
report that they could tell if patients understood or not, without specifying how, and some said 
that patients just told that they understood. There were large differences in the reliability of the 
information that decisions were based on, as this included assumptions and answers to closed and 
open-ended questions. If the HCPs ask open-ended questions instead of closed questions, there is 
a greater opportunity to pick up issues that patients have not understood.  
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5.3.4 ARVs and adverse effects 
Pharmacists have specialised knowledge on the use of medication, and therefore have a great 
potential for contributing to provide better health care. Their involvement in medical treatment of 
HIV patients is not only of benefit, but also a requirement, as described in the treatment 
guidelines. As highlighted in the guidelines, “mounting an effective ART programme requires 
more than just the drugs. Establishing an adequate cadre of well-trained health care professionals, 
laboratory technicians, pharmacists and community workers is critical for the success of this 
programme” [26]. Despite this, the pharmacists involved in the programme are few and therefore 
overworked. ARV counselling was delegated to the nurse in charge in the ARV clinic because 
too large a workload with dispensing medication for patients only. The pharmacist in charge of 
ARV provision was normally prevented from interacting with patients directly, due to the 
workload. Nurses are not educated on the same level as pharmacists to deal with drug-related 
issues, and results showed that only approximately half of the nurses involved with the treatment 
programme had received training on ARVs. However, this solution is not uncommon when 
human resources are scarce, and has also been adopted by other African countries, such as 
Ghana, Kenya and Rwanda, where ARV adherence counselling is done by nurses who have 
received specific training for this [59]. When the situation is such that major responsibility is left 
to nurses and support staff, they should be provided with extensive training in those aspects that 
are not their major competence field. 
 
Reports on percentages of patients with adverse reactions were not consistent among different 
HCPs in the system. A reason for this might be that the HCPs had not been trained in what to 
look for. Only about 20% of the respondents reported events of adverse effects during the 
previous seven days and less than half of nurses and support staff reported that they had met any 
patients during the previous seven days that received medication for symptoms of adverse effects. 
Some nurses reported that there were no side-effects among patient in their clinic. It was 
expected that the pharmacist who was preparing medication for all of the patients, and the doctors 
who were prescribing the medication would report to each other with regard to adverse effects, 
but this was not noted in this study. These interviews were conducted at different times. 
However, no factors or special events believed to influence the number of patients with adverse 
effects were identified during the period when the interviews were conducted. This inconsistency 
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might be due to miscalculations from both sides, and shows the disadvantage of a system 
operating with computers only to a limited extent.  
 
It is well known that ARVs lead to a great deal of adverse effects. Though individual differences 
exist it is most unlikely there will be any patients who do not present with adverse effects if they 
take the treatment as prescribed. Therefore, compared to what was expected, very few HCPs 
reported that they had met patients with adverse effects during the previous seven days. However, 
this is not to say that few patients truly experience adverse effects from the treatment. There 
could be many reasons why some HCPs reported that there were no patients with side-effects in 
their clinics or that they did not meet any patients with adverse effects. One aspect is that it may 
be difficult to differentiate between adverse effects and symptoms caused by HIV/AIDS, or the 
patients may have other diseases that make it difficult to know the true cause of the symptoms. 
The HCPs might expect many adverse effects and side-effects, and therefore not thought of when 
asked about adverse effects among patients. It was reported by HCPs that many patients suffer 
from alcohol abuse. This could cause both symptoms i.e. dizziness and nauseous, and therefore 
neither the patients nor the HCPs would know the true cause of the symptoms. It is a possibility 
that patients, for unknown reasons, do not always tell the HCPs about experienced adverse 
effects. This however, should not indicate that none of these patients experienced adverse effects. 
Patients may be afraid of telling, or not know the difference between symptoms they experience 
and might therefore not know if they do experience side effects.  Due to the high probability for 
adverse effects, the HCPs should expect that their patients experienced these, even if they did not 
mention any symptoms. It is also possible that if the respondents did not remember or did not 
know, they reported that there were none. Further studies need to be done to study and document 
the true occurrence of adverse effects among the HIV-positive patients on ARVs. 
 
5.3.5 Adherence 
Experiences from MSF in South Africa show that the following factors are important for long-
term adherence to ART: easy to take regimen, dispensing health facilities within easy reach of the 
patients, individual support and educational material. Standard treatment in the public sector in 
South Africa consists of three different ARVs, of which each has to be taken once or twice daily. 
In some treatment programmes patients receive combination packages with two ARVs in one 
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tablet to reduce the amount of tablets administered daily. Fixed combination tablets were not used 
in the ART programme in Grahamstown’s public facilities. One of the problems with 
combination packages is that one depends solely on one manufacturer for the supply of ARV, as 
compared to when each component of the combination therapy can be ordered separately from 
different manufacturers, depending on what is more convenient with regard to availability and 
costs. However, there is a disadvantage in using generic drugs, because the patient may be 
confused or uncertain about the treatment when colour and shape of the tablets change. 
Collection points for ARV were at the health care facilities within easiest reach of the patients 
and patients were provided with individual support and had access to educational material. This 
included leaflets and posters on different aspects of the treatment and disease, written in the three 
commonly spoken languages in the area. However, especially for the patients who cannot read, 
such written educational material will not be of great value without human resources to explain 
the meaning of these. 
 
Results showed that the most frequent methods for adherence measuring were pill count, medical 
diary/tick chart and asking questions. All these methods were based on trust in the patient, and 
are therefore of little value unless the patients tell the truth. Pill count adherence was calculated 
by counting the remaining doses of medication brought back by the patient, and then assuming 
that remaining pills in excess represented missed doses. This gives a picture of the patients’ 
adherence that is very unreliable as the sensitivity of pill counts for detecting non-adherence is 
compromised when patients remove pills without taking them, and leads to overestimation of 
adherence [62]. This was shown in the results of this study since HCPs identified that some 
patients lied to them. At the same time the HCPs had few opportunities to measure adherence in 
ways that were not based on trust.  
 
Although it is argued and seen in several research projects that sufficient level of adherence can 
be achieved in resource-limited settings, it is still a very doubtful basis for the measurement of 
adherence to only trust the patient. It was mentioned by one of the HCPs that the only way to get 
a more accurate picture of a patient’s adherence was to do blood tests. If the patients were 
adherent, the viral load would be low and CD4 count would be high. Due to a time consuming 
procedure and extra costs it is not likely that this method would be recommended as the standard 
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method for adherence monitoring in a context where both human and economic resources are 
limited. 
 
It was the opinion of HCPs that traditional medication was an important aspect to talk about with 
the patients, and respondents emphasised that traditional medication should not be used together 
with ARVs. Results showed that use of traditional medication was seen as a possible reason for 
patients not wanting to take their medication, and therefore not being adherent. A study on 
barriers to ART adherence in Botswana, conducted in private clinics, shows that the most 
common barrier to adherence reported was finances, followed by forgetting to take medication, 
running out of medications, travelling, side-effects, and patients being too busy [55]. The above-
mentioned study also showed that there was an inconsistency in patients’ self-reporting of 
adherence, and patient adherence reported by the HCPs.  
 
The importance of patient adherence is addressed by training the patients in adherence and by the 
requirement for a supporter before treatment initiation. Patients who do not show the ability to 
adhere to the treatment risk being taken off the treatment in order to give space for new patients. 
This is a consequence of a situation where resources are not sufficient to provide treatment for all 
who need it. This threat is a possible barrier for patients to be open in case of non-adherence. 
Adherence is always a challenge and there are many factors influencing adherence that are not 
related to the patients’ contexts. Such universal factors are, among others, that patients forget to 
take their medication, or that they are scared of or experience adverse effects. Some obstructions 
to adherence that the researcher became aware of by personal notifications during the time of the 
study were that some patients share their medication with others who do not receive treatment, 
patients selling their medication, patients wishing to be sick enough to be eligible for disability 
grant and beliefs that ARVs are dangerous or kill them. Other obstructions to adherence, for 
patients who wish to be adherent, are among others alcohol abuse, unpredictable events like 
funerals resulting in patients going away for longer periods than they have medication for and 
patients hiding their medication from friends and family. 
 
Though stable and reliable access to medicines is a necessity for patients’ adherence, this is not 
the only determinant. This is due to many factors influencing both the patient’s own decision on 
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how to take the medication, and the patient’s ability to take medication according to these 
decisions. 
 
Further studies need to be done to identify the adherence level among patients on ARVs. Based 
on the findings that patients do not always tell the truth and finding from the above-mentioned 
study that there is an inconsistency in patients’ and HCPs’ reporting of adherence, a study on 
adherence should include both patients and HCPs. Such a study should not rely solely on pill 
count, as this will not provide valid results. 
 
The majority of the respondents reported that they had not met any patients within the previous 
week who had told them they had forgotten to take any of the medication. The majority of the 
respondents from the questionnaire also reported that they had not met any patients during the 
previous week who they thought were unwilling to take their medication, regardless of what the 
patients had told them. It was very seldom that patients told HCPs that they didn’t want to 
continue taking their medication. There were also very few reports of patients who had 
misunderstood how to take their medication. The methods that were used to gather this 
information was mainly by communicating with the patient, and trusting them. 
 
Opinions from group discussions were that stigmas related to HIV/AIDS had not been as 
problematic as first expected, though HCPs from down referral clinics reported that many 
patients had problems with disclosure and were afraid of being stigmatised. These are not 
necessarily contradictory opinions that do not reflect the truth. It is possible that clinical nurses 
from down referral clinics were exposed to more fear or stigma from disclosure since these 
clinics were the sites where patients were diagnosed and came back regularly as part of the 
readiness programme. By the time a patient was initiated on treatment, it is clear that this patient 
disclosed their HIV-positive status to at least one person, preferably in the same household. 
Group discussions involved mainly HCPs working in either the district health office or at Settlers 
Hospital, and therefore it is less likely that they met patients in the initial stage after being 
diagnosed. As mentioned earlier, one nurse noted that many patients failed to come for follow up, 
which she thought was mainly due to poor disclosure. Even when patients have disclosed to one 
person, which is the requirement for initiating treatment [26], it is possible that the patients still 
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wish to hide their HIV status from the majority of their acquaintances, which in turn can lead to 
difficulties with adherence. According to the treatment guidelines, the preferred level of 
adherence is above 95%10. With this level of adherence 78% of the patients will achieve 
undetectable viral load. 
 
5.3.6 Excess workload for HCPs 
Working with HIV patients is challenging and time consuming, and the majority of respondents 
reported that that they had to make priorities in their work with HIV patients. The work with HIV 
patients also affected and limited the work with non-HIV patients, reported by about 90% of the 
nurses and 65% of the support staff. This situation is not unique for this context, and it is reported 
from a study on experiences of PHC facility health workers in South Africa that pressure caused 
by HIV-related illnesses leads to health care workers becoming overburdened combined with 
morbidity and mortality among health workers themselves. The report further states that absence 
of complementary resource and inputs has led to HCPs providing HIV/AIDS services in addition 
to other services in overloaded facilities, in a health care system that is already inequitable in 
resources and delivery [63]. It was found in the public treatment facilities in Grahamstown that 
work with HIV patients takes more time and effort than work with other patients, and it was 
reported that even if there were fewer HIV patients they took up more time than non-HIV 
patients. 
 
Public hospitals often experience shortage of doctors, and the Eastern Cape is the province in the 
country with the most patients per doctor [64]. At the same time there is a high migration rate of 
South African health care professionals to other countries, which contributes to limited human 
resources. This is demonstrated by a report on global migration of pharmacists. According to the 
report 1000 pharmacists graduated in South Africa in year 2001. The same year 600 pharmacists 
emigrated from South Africa to other countries [65]. 
 
                                                 
10 With a treatment regimen of two tablets in the morning and three tablets in the evening the total number of tablets 
to be taken during the 28 days is 140 tablets. To achieve 95% adherence the patient can only miss 7 tablets during 
this period. If the patient during a period of 28 days misses the morning dosage twice and misses the evening dosage 
once this is already 7 tablets missed. 
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The majority of HCPs reported that they had met 1-10 patients for each of the categories VCT 
and follow-up during the previous seven days. This shows that the number of patients is still 
small. Results showed that the clinics had adopted different strategies for queuing patients. Some 
HCPs report that their clinic had separate queues for HIV patients whereas HCPs in other clinics 
reported that they did not want to discriminate among the patients, and therefore they all patients 
queued together. Waiting time was shown to be difficult to quantify in many cases since it 
depended on many different factors. Observations showed that the waiting time was sometimes 
used to educate patients while they were waiting, but the information provided could not be 
evaluated in this study due to the language barrier. 
 
It was identified in the study that HCPs feel that the work with HIV patients was challenging. 
Many reported that they had met patients with special needs presenting problems that could not 
be dealt with at the health care facility before the patients left.  
 
5.3.7 Training of HCPs 
A report from 2002 highlights that resources spent on training of people to implement prevention, 
care and treatment is the most essential need when expanding the capacity of health systems to 
address HIV/AIDS [66].  
 
It was found in the study that training was not compulsory, but all of the respondents reported 
that training was a necessity for the work they were doing. About 80% of the respondents had 
received some kind of training, but the amount and kind of training varied greatly. The reason for 
this may be that it becomes harder to prioritise for both the HCP and the management at the clinic 
to take initiative for the HCP to go through training when it is not compulsory. Training might 
not be provided in the same town so the HCPs must leave their home, which can be very 
inconvenient. Going for training also implies that the HCP must take time off from work, and 
must either be replaced or the clinic will be understaffed during this period. Research from other 
treatment facilities in South Africa has shown that the additional time required for staff to attend 
advanced training courses is not always permitted by managers because of nursing shortages 
[63]. Though long-term effects of trained staff could possibly serve more benefits for the clinic, it 
might not be prioritised enough to be put in practise. If the HCPs are not trained sufficiently to be 
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able to provide the patient with sufficient health care themselves they might either rely on 
colleagues for assistance or the patient might leave the treatment facility without appropriate 
follow up. This can lead to great discrepancy in care provided from time to time, based on how 
much training the specific HCP counselling the patient has undergone. This in turn could create a 
higher burden on the treatment facility than necessary. EQUINET Africa11 also states that ART 
programmes in public sector have been constrained by poor infrastructure and poorly trained 
health care professionals [23]. 
 
The results showed that all of the CHWs reported that they had received training. This, however, 
was not the general picture for the categories of HCP with higher education. Most of the nurses 
and none of the pharmacists acknowledged that they had received training, even though their 
responsibility implied that they had more knowledge of HIV treatment than was average for 
HCPs who were not working with HIV patients. This may be due to lack of standardised training. 
Continued Professional Development (CPD) is not a requirement for the HCP to keep their 
position. Many of the respondents commented spontaneously that they wanted more training. 
This indicates that they acknowledge the challenges in this work and are motivated to learn more. 
It’s a great facilitating factor that workers are motivated to learn more, and should not be 
overlooked. The most frequently reported training was counselling, which the majority of the 
respondents had received training in. This is one of the main responsibilities for community 
health workers and the majority of support staff had received training in counselling.  
 
Training varied greatly and there were few standard responses with regard to what kind of 
training that has been provided, by whom, and how many days it lasted. Results show that some 
HCPs did not see in-service-training as specific training, whereas other respondents reported the 
same kind of training as the only training they had been provided with and acknowledged this as 
specific training. This indicates that HCPs from different professions did not necessarily 
acknowledge the same initiatives as specific training. It is important to keep in mind that the 
variety of the different professions involved in the work with HIV-positive patients represents a 
huge span of educational background, from no prior experience with health care by some of the 
support staff, to nurses, doctors and pharmacists, educated specifically for working with health 
                                                 
11 Regional Network on Equity in Health in Southern Africa 
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care. The study also showed that the group with the least education reported that they have 
received more training.  
Support staff plays a major role both with regard to health-related issues, and with regard to 
social aspects, and hence may be exposed to a wide spectre of problems. One social worker was 
appointed for the work, and major assistance in social assessment is provided by support staff. 
With appropriate training HCPs can manage a greater variety of work tasks, and the system 
becomes more flexible and less dependent on individuals. Investment in training is therefore of 
great importance for development of the system. 
 
Lack of training is not a necessary outcome of limited resources, as other countries have proved 
ability to provide health care workers with standardised training. In Botswana, all staff involved 
in care of patients receiving ART, including doctors, nurses, counsellors and pharmacy staff, are 
required to receive standardised training [56]. The training programme, called KITSO, consists of 
workshops, seminars, participant presentations, group learning, instructional videos and CD 
ROMs. All participants in the training programme must successfully complete four core modules 
of training and one elective module, which are based on the participant’s field of expertise [67]. 
 
5.3.8 Policy and practice 
A report by the Treatment Action Campaign (TAC) and AIDS law project, from 2004, claims 
that the degree of prioritisation and political commitment to services has not been matched with 
the substantial effort directed at implementing the Operational Plan at district and provincial level 
[68]. It is highlighted in this report that hospitals and clinics are under pressure to start providing 
treatment service while they are not getting the additional capital or human resources that the 
plan promises. In Grahamstown it is only Settlers Hospital that has been provided with extra 
staff, while the down referral clinics were operating with same capacity as prior to ART 
programme initiation. This affects the work and care provided for both HIV patients and non-
HIV patients. The Operational Plan also highlights the need for private partnership. According to 
the group discussions, the cooperation with the private sector was very limited from the 
beginning, and private practitioners did not follow the same guidelines as those in the public 
sector. However, this situation was reported to be improving, as private doctors were starting to 
pay attention to the governmental guidelines for ART.  
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The financial resources needed to scale up the treatment programme provide a challenge in a 
resource-limited country. Money is not only needed for the medication, but treatment facilities 
need upgrading and HCPs need to be trained. But money can be saved by investing in ART 
programmes. A study on cost-effectiveness of ART in South Africa, conducted by the University 
of Cape Town, shows that the benefits of a public sector rollout of ART outweigh the costs of not 
providing this treatment [69]. 
 
5.4 Recommendations 
Need for training 
All health care professionals working with HIV patients should receive specific training in the 
field of HIV/AIDS. Training should be made a requirement for HCPs working with HIV patients, 
and that each HCP must show a certain level of knowledge after the course to receive a certificate 
of approved training. How the training should be organised for different categories of HCPs must 
be thought through carefully, to decide what level of training that should be standard for each 
group of HCPs. Based on their responsibility in the treatment HCPs should be trained on 
HIV/AIDS, adherence, patient counselling, adverse drug reactions, HIV testing, ARV counselling 
and communication.  
 
While expanding of the treatment programme to Settlers Day Hospital is still in the planning 
stage, it is important to address the need for training of new recruited HCPs prior to roll-out. 
 
Programme structure 
It should be determined what works better: a structure with one specific nurse for the HIV 
patients, or if all nurses should do follow up of HIV patients. At present the organisation of the 
treatment structure is not the same in all clinics. It is possibly time efficient to have one special 
nurse dealing with all patients, because this nurse will know the situation for all of the HIV 
patients in the clinic and can work independently so that less time is spent asking for advice or 
about patient history. A constraint with having a limited number of nurses working with the HIV 
programme is that everything depends on very few people, who sometimes will be unavailable. 
For other HCPs to be able to fill someone’s place it is necessary that there are routines and 
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procedures to follow. Such systems are not in place in this particular context. Another concern 
with regard to keeping a special nurse for HIV patients is confidentiality, since the HIV patients 
will be separated and treated differently from the rest of the patients. 
 
Recruitment of health care professionals 
There is a need for recruitment of more staff. Solutions for the shortage of staff can be to recruit 
nurses and doctors from abroad, but this will raise a problem if the workers are unable to speak 
local languages. Another possible solution to the problem of lack of HCPs is to train more CHWs 
and other less specialised staff to carry out many of the routine tasks, and to ease the workload of 
doctors [70]. Due to the high migration rate, it should be made more attractive for HCPs to stay 
in South Africa.  
 
Most of the work with dispensing and recording was done manually. The potential for facilitated 
work tasks by a more extensive use of computer systems should be evaluated. 
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6 Conclusion 
Many different categories of health care professionals are working together to provide treatment 
and follow-up for HIV-positive patients enrolled in the ART programme in Grahamstown’s 
public sector. Patients meet with HCPs who are South African, and who most often can 
communicate in the patients’ mother tongue.  
 
After diagnosed as HIV-positive, the patients require special help both with regard to their 
medical condition, to handle daily life activities and to handle the mental pressure that 
accompanies this disease. The counselling in VCT and the following “patient readiness 
programme” ensure that patients are not started on ART without first being prepared for 
difficulties they might meet. In this work, major responsibility is given to HCPs with lack of 
sufficient training. There is a need for training and updates due to challenges in the work with 
HIV-positive patients. The educational level among HCPs involved ranges from support staff 
without prior experience with health care, to HCPs like nurses, pharmacists and doctors with 
years of health care education. No extra staff have been provided to the down referral clinics after 
implementation of the ART programme, and due to time pressure the HCPs have to make 
priorities in what they include in their work with HIV patients. Therefore it is not possible to 
always deal with all problems patients may present with right away. Time pressure also leads to 
situations with no time to for patients to ask questions, or not enough time for counselling. 
However, HCPs try their best to deal with all problems while the patients are present, since they 
can not be sure that these patients will come back later.  
 
In this treatment programme, adherence is seen as the most important aspect to discuss with the 
patients. Measuring of adherence is based on trust in patients, although in many cases it is 
difficult to know what really happens. The HCPs are motivated to learn more, and do a great job 
to minimise the negative outcomes for patients in a setting where resources are scarce.  
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3TC: Lamivudine 
AE: Adverse Effects 
ADR: Adverse Drug Reactions 
AIDS: Acquired Immunodeficiency Syndrome 
ANC: Antenatal Clinic 
ARV: Antiretroviral 
ART: Antiretroviral Therapy 
AU: African Union 
CHW: Community Health Worker 
CCW: Community Care Worker  
CPD: Continued Professional Development 
D4T: Stavudine 
DAART: Directly Administered Antiretroviral Therapy 
DDI: Didanosine  
DOT: Directly Observed Treatment 
ECA: Economic Commission for Africa 
EFV: Efavirenz 
FDA: Food and Drug Administration 
FI: Fusion Inhibitors 
HAART: Highly Active Antiretroviral Therapy 
Hb: Haemoglobin 
HCF: Health Care Facility 
HCP: Health Care Professional 
HIV: Human Immunodeficiency Virus 
IEC: Information, Education and Communication 
KZN: KwaZulu-Natal 
MLSA: Makana Local Services Area 
MSF: Medicines Sans Frontiers 
NGO: Non Governmental Organisation 
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NNRTI: Non Nucleoside Reverse Transcriptase Inhibitors 
NRTI: Nucleoside Analogue Reverse Transcriptase Inhibitors 
NVP: Nevirapine 
OEAS: Optimal Equitable Allocation Strategy 
OR: Operational Research 
PMTCT: Prevention of Mother To Child Transmission 
SANAC: South African AIDS Council 
SDH: Settlers Day Hospital 
SH: Settlers Hospital 
STD: Sexually Transmitted Diseases 
STI: Sexually Transmitted Infections 
VCT: Voluntary HIV Counselling and Testing 
ZDV/ AZT: Zidovudine 
Lop/r: Lopinavir/Ritonavir 
PHC: Primary Health Care 
TB: Tuberculosis 
UN: United Nations 
UNAIDS: Joint United Nations Programme on HIV/AIDS 
WHO: World Health Organization 
WTO: World Trade Organization 
ZAR: South African Rand 
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Appendix 1  
 
Operational Research 
There is an urgent need for operational research to aid in the direction of care programmes that 
can not be overemphasised. In the process of creating and scaling up programmes for prevention 
and care it is essential to monitor and evaluate the effectiveness of these programs [30]. The 
WHO Operational Research Agenda for “3 by 5” initiatives [71] describes ways to gather 
strategic information that will indicate how ART delivery systems in resource-limited settings 
work. Activities of priority according to the agenda are among others “to identify ways to define 
the externalities of ART scale-up on health systems’ performance”, and “to incorporate new 
knowledge rapidly back into ART programme policy and practice”. As treatment programmes 
proceed it is important to provide clear evidence that this is strengthening health systems, and it is 
important to identify constraints and facilitating factors of the system. When this information is 
gathered it is necessary to feed back information for decision making to where operational 
research is to be carried out and in settings facing a similar situation.  
 
The 10/90 Gap 
The principles of universal comprehensive health care, by combining medical and social 
interventions, were emphasised by the 1978 Alma Ata Declaration. This is far from being 
implemented at present, and even in countries considered to have good functioning systems, 
some people are not satisfied by the countries’ ability to care for the poor. While poor health has 
the tendency to increase poverty, “good health is central for (a) the promotion of development; 
(b) the fight against poverty; and (c) global security” [72]. In order to improve the design of 
health interventions, policies and service delivery, it is important to conduct health research. This 
is to make sure that decisions made are built on recommendations that are evidence based, so that 
resources available are spent in the most effective way to combat poor health and disease. The 
current situation is such that only 10% of health research funds from public and private sector are 
devoted to 90% of the world’s health problems, referred to as the “10/90 Gap”, and funds are not 
always used as effectively as possible. Better health for anyone, anywhere on earth, is a global 
good that would benefit everybody else. Therefore health research, which is a key determinant of 
health improvements, is also to be seen as a public good [72].  
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Appendix 2  
Patient and Health Care Personnel interaction study 
Consent Form 
 
Title of Research Project: The role of the different health care personnel in the work with HIV 
patients in the public sector in Grahamstown 
Principal Investigator: Karine Wabø Ruud 
Introduction: I am a student from Rhodes and am conducting research on the interaction 
between health care personnel and HIV patients in Grahamstown. It would be highly appreciated 
if you as health care professional participated in my research. Please ask any questions about this 
study before you agree to join in. You may also ask questions at any time after joining the study. 
Purpose: To find out how the health care professionals work with regard to HIV patients in the 
public sector. 
Procedure: Questionnaire 
Risk/ Discomfort: None 
Confidentiality: You will remain anonymous in this study. The details of your name and 
profession will only be available to Karine Wabø Ruud 
Compensation: You will not be paid any money to participate in this study. 
 
Consent: 
I have read/ or understood the conditions about and I consent to voluntarily participate in this 
research study. I realize I am free to withdraw my consent without any explaining reason and to 
withdraw from this study at any time without negative consequences. I hereby consent to the use 
of visual images (photos etc) involving my participation in this research. 
 
 
Name of subject (Please print)…………………………………………………………. 
 
Signature or thumbprint of subject……………………………………………………... 
 
Address…………………………………………………………………………………. 
 
Date…………………………………………………………………………………….. 
 
 
Name of witness to consent…………………………………………………………….. 
 
Signature of witness……………………………………………………………………. 
 
Name of person obtaining consent……………………………………………………... 
 
Signature of person obtaining consent…………………………………………………. 
 
Date…………………………………… 
 
Name of clinic………………………………………………………………………... 
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Appendix 3 
The role of health care personnel (HCP) in work with HIV patients      
       
1 Demographics      
1.1 Age       
1.2 Gender Male
1 Female2     
1.3 Nationality SA
1 Other2     
1.4 First language Xhosa
1 Afrikaans2 English3    
1.5 What different languages do you speak?       
 a) Xhosa  Yes
1 No2   
 b) Afrikaans  Yes
1 No2   
 c) English  Yes
1 No2   
 d) Other  Yes
1 No2   
1.6 What is your profession? Reg. nurse
1 CHW2 Pharm3 Doctor4   
  
Social 
worker5 
Nursing 
assistant6 
Dietitian7 CCW8  
  
Clinic ass9 Health 
educator10 
    
1.7.1 How long have you been working in this clinic (months)? 0-3
1 4-62 7-123 13-184 19-365 >3yrs6   
1.7.2 How long have you been working with HIV (months)? 0-3
1 4-62 7-123 13-184 19-365 >3yrs6   
1.7.3 For how long have you been in this profession (months)? 0-3
1 4-62 7-123 13-184 19-365 >3yrs6   
1.8 Which of the following patient / HCP interactions do you take part in?       
1.8.a Pre-testing counselling in VCT Yes
1 No2      
1.8.b Testing in VCT Yes
1 No2      
1.8.c Post-testing counselling in VCT Yes
1 No2      
1.8.d Patients' monthly ARV collection Yes
1 No2      
1.8.e Counselling of patients who start ARV Yes
1 No2      
1.8.f Follow up of patients between testing positive and initiation of ARV Yes
1 No2      
1.8.g Home visits Yes
1 No2      
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2 General aspects in follow-up       
2.1.1 Did you see HIV patients today? Yes
1 No2      
2.1.2 If no, when was the previous day you saw HIV patients?       
2.1.3 How many patients did you see during the last 7 days for VCT?       
2.1.4 How many patients did you see during the last 7 days for follow-up?       
2.2 How many patients during the last 7 days did you talk to in:      
2.2.a Xhosa  All
1 Most2 Half3 Few4 None5  
2.2.b English  All
1 Most2 Half3 Few4 None5  
2.2.c Afrikaans All
1 Most2 Half3 Few4 None5  
2.3 How many times during last week did you have someone translate to the patients?        
2.4.1 
 
Are there sometimes important issues that for any reason are not being dealt with before the patient leave 
the health facility?  
Yes1 No2     
2.4.2 
Can you list any of the reasons?         
             
2.5.1 Do you know the average interaction time between you and the patients?  Yes
1 No2      
 If yes, please specify in minutes;      
2.5.2
a 
First time (minutes) <101 10-202 25-403 45-604 >605   
2.5.2
b 
Follow up (minutes) <101 10-202 25-403 45-604 >605   
2.6.1 Do the patients complain about anything? A) Very
1 often Often2 Not often3    
 B) Daily
1 Once2 Twice3 Trice4 <weekly5   
2.6.2 
 
 
If yes, please specify; 
     
 
 
2.7 How long is the average waiting time for patients at this unit (minutes) Minimal
1 10-302 35-603 >604    
 
 Open 
answer5 
Don’t know5    
       
3 Training of involved Health Care Personnel      
3.1 Do you think your work with HIV patients require any specific training? Yes
1 No2     
3.2 Have you been sent to do any specific training to be able to do this work with HIV patients? Yes
1 No2     
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3.3 If yes, can you specify the contents of the training?      
 a) ARVs Yes
1 No2    
 b) Counselling Yes
1 No2    
 c) Testing Yes
1 No2    
 d) HIV Yes
1 No2    
 other:      
3.4 How many days did the training last? 
a) b) c) d)   
3.5 
 
Are you aware of any documents explaining your job description? Yes1 No2    
 
      
4 
Patient / Health Care Personnel Interaction      
4.1 
Does your work involve direct patient contact? If yes, proceed; Yes1 No2     
4.2 Which of the following subjects do you deal with:      
4.2.a Adherence monitoring Daily
1 Weekly2 Monthly3 Never4   
4.2.b Explaining how to use medication Daily
1 Weekly2 Monthly3 Never4   
4.2.c Handing out medication Daily
1 Weekly2 Monthly3 Never4   
4.2.d Monitor adverse effects Daily
1 Weekly2 Monthly3 Never4   
4.3 Are the patients allowed to meet you before their scheduled date? If yes proceed; Yes
1 No2     
4.4 What are the reasons for which a patient comes to see you without an appointment?      
4.4.a Patient is going away and need a new appointment Yes
1 No2     
4.4.b Run short of tablets Yes
1 No2     
4.4.c Patient comes late for the appointment Yes
1 No2     
4.4.d Side effects Yes
1 No2      
4.4.e Family or friends were worried Yes
1 No2      
4.4.f Patient was worried about health Yes
1 No2      
4.4.g Other:        
4.5.1 Where there any patients during last week who came to see you without an appointment? Yes
1 No2      
4.5.2 If yes, how many?         
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4.6 What do you think is the most important aspect to discuss with your HIV patients? 
12           
       
4.7 Did you discuss any of the following issues with HIV patients today/ the previous day you met patients:      
4.7.a Adverse effects Yes
1 No2       
4.7.b Money Yes
1 No2       
4.7.c Diet/ nutrition Yes
1 No2       
4.7.d Family situation Yes
1 No2       
4.7.e Disclosure about status Yes
1 No2       
4.7.f Treatment failure Yes
1 No2       
4.7.g Family planning Yes
1 No2       
4.7.h Protection of partner/ children Yes
1 No2       
4.7.i Supporter Yes
1 No2       
4.7.j Weight change Gain
1 Loss2 N/A3 General4   
4.7.k Lifestyle (smoking/ drinking) Yes
1 No2      
4.7.l Other? Yes
1 No2      
4.8 During the last seven days, could you recognize any of the patients from their last meeting? Yes
1 No2     
4.8.1 If yes, how many? None
1 Few2 Half3 Majority4  All5  
4.9 
 
How often during last seven days did you experience that patients had misunderstood from earlier visit how 
to take their medication? 
      
4.10.
1 
Are there some questions you always ask the patients? Yes1 No2      
4.10.
2 
 
If yes, please specify 
 
        
4.11.
1 
Are there other questions that you generally don't ask unless there are specific problems? Yes1 No2      
4.11.
2 
Can you think of any situation when the patient need special help compared to the average? Yes1 No2       
 Please specify;      
4.12 How often during the last 7 days did you talk to a patient about change dosage/ formulation?       
                                                 
12 Adherence1 / Nutrition2 / Disclosure3 / Side effects4 / Any problems5 / Keep appointment6 / Sex7 / General health8 / Use condom9 / Avoid pregnancy10 / CD4+, 
immunity11 / HIV, Aids12 / Treatment for life13 / Alcohol14 / Drugs15 / Take tablets well16 
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4.13 
 
What kind of feedback do you get from the patients that tell you how well they understand what you 
explain to them? 
          
4.14 Which methods do you use to indicate patient adherence?        
 a) Tick chart Yes
1 No2    
 b) Ask questions Yes
1 No2    
 c) Pill count Yes
1 No2    
 d) Other:       
4.15.
1 
Do you know the exact number of patients expected to be seen for VCT every day? Yes1 No2     
4.15.
2 
Do you know the exact number of patients expected to be seen for scheduled visit every day? Yes1 No2      
4.16.
1 
 
How many patients during the last 7 days told you that they didn’t want to continue to take their 
medication? 
     
4.16.
2 
 
How many times during the last 7 days did a patient tell you that they forgot to take their medication?      
4.17.
1 
How many patients during the last 7 days told you about concern with regard to treatment/ disease?      
4.18.
1 
Have any patients told you that they feel more comfortable about talking to one HCP than another? Yes1 No2      
4.18.
2 
If yes, did they give any reasons why?        
4.18.
3 
 
Do you have the impression that patients are more open to any HCPs than other because of their 
profession? 
Yes1 No2     
4.18.
4 
If yes, please specify:      
4.19 
How many of the patients you have seen during the last 7 days asked questions on their own initiative? none1 few2 half3 most4 all5 Don’t know6   
4.20 Which questions are frequently asked by HIV patients?       
4.20.
a 
Side effects Yes1 No2     
4.20.
b 
How to use the medicines Yes1 No2     
4.20.
c 
Money / Grant Yes1 No2     
4.20.
d 
Other:         
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4.21.
1 
 
Have you during the last 7 days sensed that ARV patients are unwilling to take their medicines? Yes1 
 
No2     
 
4.22.
2 
 
How many HIV patients you met during the last 7 days complained about symptoms of minor side-effects?       
4.22.
3 
 
How many HIV patients you met during the last 7 days complained about symptoms of major side-effects?       
4.23 
How many of HIV patients you met during the last 7 days receive medication to treat symptoms of A/E       
4.24 Do you know how many of the patients you met during the last 7 days switched treatment due to A/E?        
4.25 Who, if anyone, do you confer with if patients complain about adverse effects?       
 a) Doctor
1
 Yes1 No2    
 b) Reg. nurse
2 Yes1 No2    
 c) Pharm
3 Yes1 No2    
 d) Other
4 Yes1  No2    
4.26 Which of the adverse effects have shown to be most frequent among patients you have met?        
 a) Peripheral neuropaty
1
 Yes1 No2    
 b) Lactic Acidosis
2
 Yes1 No2    
 c) Only side effects
3 Yes1 No2    
 d) Don’t know
4 Yes1  No2    
 e) none Yes
1  No2    
       
5 ARV related questions      
5.1 
 
How many HIV patients have you explained to today/ the previous day you saw patients how to use their 
medication? 
       
5.2 
 
Have you provided any patients with new instructions about their medication today or the previous day you 
saw patients? 
Yes1 No2      
5.3 
 
When were you last time involved with an HIV patient who needed additional information because 
of new dosage or formulation? 
This 
week 1 
1-2 weeks 
ago 2 
Last 
month3 
>1 month 
ago4 
Don’t 
remember5 
  
5.4 
 
Do you sometimes repeat to HIV patients how to use their medication? Yes1 No2      
5.4.1 
 
If yes, for what reasons do you repeat?        
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6 Health Care Personnel Cooperation      
6.1 What kind of discussions about patient cases are you involved in with other HCP?      
6.1.a Discuss patient case while patient is waiting Yes
1 No2      
6.1.b Discuss patient case after patient has left Yes
1 No2      
6.1.c Patient presentations for HCP team/ review meeting Yes
1 No2      
6.1.d ARV clinic meeting at SH / Friday meeting Yes
1 No2      
6.1.e Ward round SH Yes
1 No2      
6.1.f ARV task team monthly meeting Yes
1 No2      
           
6.2.1 
 
Have you participated in any scheduled meetings during the last 7 days with other HCP because of the 
work with HIV patients? 
Yes1 No2      
6.2.2 If yes, how many?        
6.3 
 
How many times during the last 7 days did you discuss difficult patient cases with other HCP when the 
patients were not present? 
       
6.4 
 
How many times during the last 7 days did you ask someone for advice while dealing with a HIV patient?        
6.5 
 
Have you participated in any meetings during the last 7 days to discuss the present work being done with 
regard to HIV? 
Yes1 No2      
6.5.a 
 
Formal meetings Yes1 No2  
 
 
6.5.b 
 
Informal meetings Yes1 No2  
 
 
6.6 
 
Did you refer patient to other HCP during the last 7 days because of problems with regard to any of the 
following issues; 
   
 
 
6.6.a Adverse effects Yes
1 No2     
6.6.b 
Poor adherence Yes1 No2      
6.6.c 
Disease progress Yes1 No2      
6.6.d Social issues Yes
1 No2      
6.6.e Diet Yes
1 No2      
6.6.f 
Other Yes1 No2      
       
7 Questions about work      
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7.1 
 
How big part of your work during the week consists of HIV related work? 
 
       
 Percentage    Minimal
1 5-10%2 15-25%3 30-45%4 50%5 55-70%6 75-85%7 85-90%8 100%9  
  Hours/day     
  Days/week       
7.2 
Does the time pressure in any way limit your work with the patients? Yes1 No2     
7.2.1 If yes, Please specify           
7.3 
 
Do you have to make any priorities with regard to what you include in your work with HIV patients 
because of time shortage? 
Yes1 No2     
7.3.1            
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Appendix 7 
 
World Health Organisation Adults HIV and AIDS Staging System 
 
Stage I 
1. Asymptomatic 
2. Persistent generalised lymphadenopathy (PGL) 
3. Acute retroviral infection (sero-conversion illness) and/or performance Scale 1: asymptomatic, normal 
activity. 
 
Stage II 
4. Unintentional weight loss <10% of body weight 
5. Minor mucocutaneous (e.g. seborrhoea, prurigo, fungal nail infections, oral ulcers, angular cheilitis) 
6. Herpes zoster within the last five years 
7. Recurrent upper respiratory tract infection (e.g. bacterial sinusitis) (URTI) and/or performance Scale 2: 
symptomatic, normal activity. 
 
Stage III 
8. Unintentional weight loss >10% of body weight 
9. Chronic diarrhoea >one month 
10. Prolonged fever >one month 
11. Oral candidiasis 
12. Oral hairy leukoplakia 
13. Pulmonary TB within the last year (PTB) 
14. Severe bacterial infections (pneumonia, pyomyositis) 
15. Vulvovaginal candidiasis >one month / poor response to therapy and/or performance Scale 3: bedridden 
<50% of the day during the last month. 
 
Stage IV 
16. HIV wasting (8+9 or 10) 
17. Pneumocystis carinii pneumonia (PCP) 
18. CNS toxoplasmosis (Toxo) 
19. Cryptosporidiosis plus diarrhoea >one month 
20. Isosporiasis plus diarrhoea 
21. Cryptococcosis – non pulmonary 
22. Cytomegalovirus infection other than liver, spleen or lymph node (CMV) 
23. Herpes simplex infection; visceral or >one month mucocutaneous (HSV) 
24. Progressive multifocal leucoencephalopathy (PML) 
25. Disseminated mycosis (i.e. histoplasmosis, coccidiomycosis) 
26. Candida oesophageal/tracheal/pulmonary 
27. Atypical mycobacteriosis disseminated (MOTT) 
28. Non-typhoidal Salmonella septicaemia 
29. Extra-pulmonary tuberculosis (ETB) 
30. Lymphoma 
31. Kaposi’s sarcoma (KS) 
32. HIV encephalopathy (ADC) 
33. Invasive cervical carcinoma and/or performance Scale 4: bedridden >50% of the day during the last month 
 
 
 
